%PDF-1.3
%
1 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 143>>stream
x0E~uТ!F4&%-=Yν(U%TrJjd8juz=5X@Ɠw#b>LK͛( /2!3q樜Ǥ,,fث/ۃmSh,
endstream
endobj
9 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2019-03-12T13:09:44-07:00
2019-03-05T22:48:30+05:30
application/pdf
LGBT-2018-0151-ver9-Nazem_2P 62..67
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:a82738ed-0701-469e-8323-705d6c2a5aca
uuid:f4cf840e-b5de-4a19-834c-1ea2c675ec82
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
23 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.5557 Tm
0 0 0 rg
0 Tc
0 Tw
[(o)-6.9(f)-369.7(mu)-9.2(l)-7(t)-7(i)0(p)-8.1(l)-7(e)-365.1(s)-6.7(a)-8(m)0(p)-9.2(l)-7(es)-371.8(f)-6.8(o)-6.9(r)-369.7(f)0(u)-7.9(t)-7(ur)-7.9(e)-370.9(b)-6.9(io)-8.1(l)-7(o)0(g)-8(i)-7(ca)-10.3(l)-369.8(s)-6.7(ib)-8.1(l)-7(i)-7(n)0(g)-8(s)-369.5(f)-6.8(o)0(r)-370.8(t)-7(he)-9.1(i)-7(r)]TJ
0 -1.1174 TD
[(c)-8(h)-6.9(il)-8.2(d)-6.9(r)-6.8(en)-9.1(.)]TJ
7.3823 0 0 6.5614 95.074 718.9794 Tm
(1)Tj
9.843 0 0 9.843 69.7323 703.6156 Tm
[(Even)-352.3(though)-352.3(many)-352.4(lesbian)-349.9(women)-354.4(present)-355.5(for)-348.8(reproduc-)]TJ
-1.0137 -1.1116 TD
[(tive)-207.4(care)-209.4(without)-210.6(a)-203.8(diagnosis)-212.5(of)-203.8(infertility,)-207.5(they)-207.3(often)-208.4(undergo)]TJ
T*
[(a)-255.7(similar)-257.9(workup)-260.9(and)-252.1(treatment)-262.7(plan)-253.4(to)-255.8(heterosexual)-259.8(patients)]TJ
0 -1.1174 TD
[(with)-322.3(infertility.)-316.9(For)-319.9(example,)-321.3(a)-319(hysterosalpingogram)-319.3(\(HSG\))]TJ
0 -1.1116 TD
[(is)-416.8(often)-415.7(part)-420.4(of)-416.9(this)-413.4(routine)-418(screening.)-419.9(And,)-416.5(while)-416.7(lesbian)]TJ
T*
[(women)-250.7(need)-248.6(access)-252.8(to)-244.2(donor)-247.4(sperm)-249.6(and)-246.4(often)-248.7(undergo)-250.8(an)-245.3(in-)]TJ
0 -1.1174 TD
[(trauterine)-245.2(insemination)-241.7(\(IUI\),)-245.8(there)-238.3(are)-241.7(many)-242.9(different)-242.8(meth-)]TJ
0 -1.1116 TD
[(ods)-204.7(of)-203.8(cycle)-205(preparation.)-209.3(During)-203.4(a)-203.8(natural)-200.3(cycle,)-208.4(patients)-207.2(may)]TJ
T*
[(monitor)-360.5(ovulation)-357.1(with)-362.6(home)-358.1(detection)-359.4(kits)-361.6(or)-353.5(by)-359.3(an)-360.5(ultra-)]TJ
0 -1.1174 TD
-.0167 Tc
[(soun)5.2(d)-213.6(t)5.1(o)-207.9(c)-1.7(on)5.4(rm)-209.1(fol)5.1(licular)-213.6(matu)5.2(rit)5.1(y)-.5(.)-210.2(I)-.5(n)-207.9(o)-.5(l)5.1(i)-.6(go-)5.3(ovu)5.2(lat)5.1(ory)-207.9(patien)5.2(t)-.6(s)]TJ
0 -1.1116 TD
-.0162 Tc
[(or)-259.2(hy)5.7(pot)5.6(hal)5.6(ami)5.6(c)-260.4(p)0(atients,)-255.8(or)5.8(al)-259.3(o)5.7(r)-259.2(in)5.7(ject)5.6(abl)5.6(e)-260.4(medicati)5.6(ons)-253.2(can)-253.4(be)]TJ
T*
[(used)-357.2(to)-357.2(in)5.6(duce)-364.1(o)5.6(vulatio)5.6(n.)-359.6(Th)5.6(ese)-358.4(m)-1.3(edicati)5.5(ons)-357(can)-357.2(al)5.5(so)-363(b)5.6(e)-364.1(u)5.6(ti-)]TJ
0 -1.1174 TD
-.0167 Tc
[(lized)-357.6(t)5.1(o)-357.6(achieve)-353(s)-.3(up)5.2(erov)5.2(ulatio)5.2(n)-357.6(f)-.5(o)5.2(r)-357.6(patients)-351.7(w)-1.4(it)5.1(h)-357.6(u)-.5(n)5.2(e)-1.7(xp)5.2(lai)5.1(n)-.5(ed)]TJ
0 -1.1116 TD
-.0164 Tc
[(inferti)5.4(lity)5.5(.)-353.9(A)-352.4(tri)5.4(gger)-357.3(s)0(h)5.5(o)-.2(t)-351.7(w)-1.1(it)5.4(h)-351.6(human)-351.6(cho)5.5(r)-.2(io)5.5(nic)-352.7(g)-.2(o)5.5(n)-.2(ado)5.5(t)-.3(ro)5.5(pin)]TJ
T*
-.0167 Tc
[(\(hCG\))-409.4(is)-409.3(often)-409.5(emp)5.2(loy)5.2(e)-1.7(d)-409.5(t)-.6(o)-409.5(o)-.5(p)5.2(timall)5.1(y)-415.2(t)5.1(i)-.6(me)-410.6(a)-410.6(d)-.5(o)5.2(nor)-409.4(IUI)-409.4(for)]TJ
T*
-.0157 Tc
[(all)-339.5(t).4(y)6.2(p).5(es)-339.1(of)-339.3(c)5.1(y).5(cl)6.1(es.)-341.7(U)5.4(nli)6.1(k).5(e)-340.5(h).5(et)6.1(ero)6.2(s).7(ex)6.2(ual)-339.5(p).5(a)5.1(tie)5.1(nts,)-335.9(les)6.4(b).5(ian)-339.3(c)5.1(ou-)]TJ
0 -1.1174 TD
-.0163 Tc
[(ples)-339.7(someti)5.5(mes)-334(have)-335.3(the)-335.3(uniq)5.6(u)-.1(e)-341.1(o)5.6(ppo)5.6(rtun)5.6(ity)-339.9(t)5.5(o)-339.9(ch)5.6(oose)-335.3(w)-1(hi)5.5(ch)]TJ
0 -1.1116 TD
-.0167 Tc
[(par)5.3(t)-.6(ner)-288.5(w)-1.4(il)5.1(l)-294.4(c)-1.7(arry)-288.5(the)-289.7(g)-.5(est)5.1(a)-1.7(ti)5.1(on)-294.3(as)-294.1(in)-288.5(man)5.2(y)-294.3(c)-1.7(ases)-288.3(bot)5.1(h)-294.3(p)-.5(artners)]TJ
T*
-.0165 Tc
[(may)-213.4(have)-214.6(the)-214.6(r)-.3(epro)5.4(duct)5.3(i)-.4(ve)-214.6(ab)5.4(ili)5.3(ty)-213.4(to)-213.4(do)-213.4(so.)-215.8(S)-.2(o)5.4(m)-1.5(e)-214.6(c)-1.5(o)5.4(uples)-219(o)5.4(p)-.3(t)-213.6(t)-.5(o)]TJ
0 -1.1174 TD
.0125 Tc
[(und)5.6(er)5.7(go)-351.5(co)5.6(-in)-351.5(v)-.1(i)5.5(t)-.2(r)5.7(o)-357.2(fert)5.5(il)5.5(izati)5.5(o)-.1(n)-351.5(\()-.1(co-I)5.7(VF)5.8(\),)-353.8(al)5.5(so)-351.5(co)5.6(mmon)5.6(ly)]TJ
0 -1.1116 TD
.0117 Tc
[(ref)4.9(e)-2.1(r)4.9(r)-.9(ed)-381.1(to)-381.1(as)-386.6(r)4.9(e)-2.1(cep)4.8(t)-1(i)4.7(o)-.9(n)-381.1(o)-.9(f)-381(o)4.8(ocyt)4.7(es)-380.9(fr)4.9(om)-382.3(p)4.8(a)-2.1(r)4.9(t)-1(n)4.8(e)-2.1(r,)-377.6(in)-381.1(o)4.8(r)-.9(d)4.8(e)-2.1(r)]TJ
T*
[(for)-386.9(bo)4.7(th)-386.9(part)4.6(ners)-392.5(t)4.6(o)-386.9(share)-388.1(i)-1.1(n)-386.9(t)-1.1(h)4.7(e)-393.8(exp)4.7(e)-2.2(r)4.8(i)-1.1(ence)-393.8(o)4.7(f)-392.6(b)4.7(i)-1.1(ol)4.6(og)4.7(ical)]TJ
0 -1.1174 TD
.0118 Tc
[(paren)4.9(t)-.9(i)4.8(n)-.8(g)4.9(.)]TJ
7.3823 0 0 6.5614 100.5732 466.9227 Tm
0 Tc
(2)Tj
9.843 0 0 9.843 69.7323 451.5589 Tm
[(Choosing)-245.9(the)-246.5(ideal)-250(treatment)-251.1(plan)-247.6(that)-247.7(minimizes)-251(cost)-241.6(and)]TJ
-1.0137 -1.1116 TD
[(time)-467.8(and)-459.5(optimizes)-468.7(the)-459.6(likelihood)-467.7(of)-462.9(achieving)-462.9(a)-463(healthy)]TJ
0 -1.1174 TD
[(baby)-207.2(can)-201.5(be)-205(challenging)-206.1(for)-204.8(lesbian)-205.9(patients)-201.4(as)-204.8(data)-202.7(regarding)]TJ
0 -1.1116 TD
[(ART)-236.8(outcomes)-231.2(in)-232.7(this)-234.9(population)-231.4(are)-236(limited)-235.2(and)-229.1(conicting.)]TJ
T*
[(Although)-395.8(some)-398.3(studies)-394.6(have)-392.6(shown)-392.1(no)-393.9(difference)-401.6(in)-394(preg-)]TJ
T*
[(nancy)-261.3(rates)-255.4(when)-259.9(comparing)-255.5(lesbian)-263.5(women)-256.4(with)-259(heterosex-)]TJ
0 -1.1174 TD
[(ual)-413.5(women)-417.7(undergoing)-409.7(the)-413.5(same)-416.7(treatment)-418.2(with)-408.7(ovulation)]TJ
0 -1.1116 TD
[(induction)-213.1(\(OI\))-206.8(and)-211.8(IUI,)]TJ
7.3823 0 0 6.5614 150.5196 379.2188 Tm
(35)Tj
9.843 0 0 9.843 163.6724 374.8535 Tm
[(others)-209.3(have)-208.3(shown)-207.8(improved)-212.9(preg-)]TJ
-10.5575 -1.1116 TD
[(nancy)-226.7(rates)-226.6(among)-226.8(lesbian)-223.2(women)-227.6(compared)-226.6(with)-224.4(heterosex-)]TJ
0 -1.1174 TD
[(ual)-304.1(women)-302.5(undergoing)-300.3(ART)-305.9(treatment.)]TJ
7.3823 0 0 6.5614 217.1905 357.3354 Tm
(6)Tj
9.843 0 0 9.843 69.7323 341.9716 Tm
[(This)-316.6(study)-310.7(aimed)-314.5(to)-313.4(characterize)-321.1(the)-309.9(typical)-315.7(reproductive)]TJ
-1.0137 -1.1116 TD
[(experience,)-406.3(specically)-402.7(cycle)-400.8(characteristics)-403.7(and)-396.1(treatment)]TJ
0 -1.1174 TD
[(outcomes,)-246.1(of)-244.1(lesbian)-246.2(women.)-248.4(The)-241.8(study)-241.6(also)-247.4(sought)-242.7(to)-244.2(deter-)]TJ
0 -1.1116 TD
[(mine)-369.8(whether)-368.1(there)-365(are)-368.5(differences)-367.9(in)-365.2(pregnancy)-364.7(outcomes)]TJ
T*
[(when)-323.2(comparing)-318.8(lesbian)-321.1(women)-319.8(undergoing)-317.5(different)-323.4(types)]TJ
T*
[(of)-272.9(ART)-277.1(treatments)-280.8(as)-273.9(well)-271.6(as)-273.9(lesbian)-280.8(women)-273.7(and)-275.2(heterosex-)]TJ
0 -1.1174 TD
[(ual)-332.9(women)-331.3(undergoing)-334.8(the)-327.1(same)-336.1(type)-328.2(of)-330.5(treatment.)-335.2(The)-328.2(in-)]TJ
0 -1.1116 TD
[(tention)-435.5(of)-434.1(the)-436.6(study)-431.7(was)-431.4(to)-434.3(better)-435.4(dene)-433.9(the)-436.6(reproductive)]TJ
T*
[(experience)-212.8(for)-210.6(lesbian)-211.7(couples)-205.8(seeking)-211.6(care)-209.4(at)-210.8(a)-203.8(fertility)-213.2(prac-)]TJ
0 -1.1174 TD
[(tice)-525.4(and)-522.8(determine)-527.5(the)-523(ideal)-520.7(mode)-525.2(of)-520.5(treatment)-527.6(for)-521.6(this)]TJ
0 -1.1116 TD
[(unique)-301.6(group)-305(of)-295.9(women.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 204.7181 Tm
(Methods)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 188.2771 Tm
[(This)-322.3(single)-7.8(-center)-11.3(,)-314.5(retrosp)-8.7(ective)-321.4(cohort)-318.9(analy)-8(sis)-319.8(includ)-8(ed)]TJ
-1.0137 -1.1116 TD
[(women)-314(2544)-316.5(years)-312.9(of)-307.4(age,)-314.3(who)-309.4(underw)-8.6(ent)-309.9(ART)-311.7(treatm)-10.4(ent)]TJ
0 -1.1174 TD
[(at)-343.3(an)-343.2(acade)-10.2(mic,)-343.3(privat)-8(e)-342.1(fertili)-9.3(ty)-342.1(practi)-9.2(ce)-344.3(betwe)-8.8(en)-343.2(2006)-344.2(and)]TJ
0 -1.1116 TD
[(2018.)-244(Lesbia)-10.1(n)-243(and)-240.6(hetero)-9(sexual)-245(women)-244.9(who)-246.1(pursue)-7.5(d)-237.2(natura)-9(l)]TJ
T*
[(cycle)-9.1(s)-415.6(o)0(r)-416.9(O)0(I)-412(with)-420.2(IUI)-418.8(with)-414.5(a)-417(cryopr)-7.7(eserve)-9.9(d)-410(sperm)-422.4(source)]TJ
0 -1.1174 TD
[(were)-520.2(i)-7(denti)-7.9(ed)-516(in)-514.9(an)-516(elect)-9.3(ronic)-519.4(medic)-9.2(al)-516.1(record)-521.5(datab)-8(ase)]TJ
0 -1.1116 TD
[(and)-280.9(includ)-8(ed)-279.8(in)-278.8(the)-281.1(study.)-285.3(Patien)-9(ts)-278.6(underg)-7.7(oing)-281(OI)-279.5(for)-279.7(multi)-7.1(-)]TJ
T*
[(ple)-309.9(indica)-9.2(tions,)-308.5(includ)-8(ing)-308.7(anovul)-7.9(atory)-306.3(disorde)-8.8(rs)-307.2(or)-307.4(polycy)-7.9(s-)]TJ
T*
[(tic)-540.4(ovary)-536.5(syndrom)-8.7(e)-532.1(\(PCOS\))-8.1(,)-533.3(unexpl)-7.9(ained)-537.9(infert)-8(ility,)-539.3(and)]TJ
0 -1.1174 TD
[(male)-313.4(factor)-314.3(infert)-8(ility,)-309(were)-312.8(included.)-314.3(PCOS)-305.5(was)-310.4(diagno)-7.9(sed)]TJ
0 -1.1116 TD
[(based)-370.5(on)-365.1(Rotte)-8(rdam)-363.9(criter)-9.1(ia.)]TJ
7.3823 0 0 6.5614 175.2944 83.0551 Tm
(7)Tj
9.843 0 0 9.843 182.5511 78.6897 Tm
[(Patien)-9(ts)-365(with)-368.4(an)-360.5(endom)-7.9(etrial)]TJ
-12.4755 -1.1116 TD
[(thickn)-8(ess)-355.4(l)-7(ess)-355.4(than)-357(6)-168.1(m)0(m)-350.2(a)0(t)-354.8(the)-355.9(time)-358.4(of)-353.5(IUI)-355.4(were)-358.9(exclu)-8(ded)]TJ
0 -1.1174 TD
[(from)-437.5(the)-436.6(analy)-8(sis.)-438.5(Patien)-9(ts)-434.1(using)-437.4(inject)-9.3(able)-438.8(gonado)-7.8(tropin)-6.8(s)]TJ
25.5097 67.9473 TD
.0071 Tc
[(f)7.1(o)7.1(r)-410.8(O)-6.4(I)-420.2(o)-5.5(r)-420.2(wi)-5.6(th)-420.2(l)-5.6(e)-6.7(ss)-420(t)-5.6(h)-5.5(an)-420.2(5)-420.2(m)-6.7(il)-5.6(li)-5.6(on)-426(to)-5.5(ta)-6.7(l)-420.3(m)-1(o)-5.5(t).1(i)-5.6(l)-5.6(e)-421.4(sp)-5.5(er)-5.5(m)-421.4(o).2(n)]TJ
0 -1.1174 TD
.0122 Tc
[(s)5.5(e)-1.6(men)-265.4(a)-1.6(n)5.3(a)-1.6(l)5.2(y)-.4(s)5.5(i)-.5(s)-265.2(\()-.4(S)5.5(A)-1.3(\))-265.3(a)-1.6(t)-265.5(t)5.2(he)-266.5(ti)5.2(me)-266.5(o)5.3(f)-271.1(I)5.4(U)-1.3(I)-265.3(w)4.5(ere)-266.5(a)4.2(ls)5.5(o)-271.1(e)4.2(xclu)5.3(ded.)]TJ
0 -1.1116 TD
.0132 Tc
[(D)5.5(u).6(r)6.4(i).5(ng)-316.2(t)6.2(h).6(e)-317.4(s)6.5(tud)6.3(y)-316.2(ti)6.2(me)-317.4(f)6.4(r).6(a)5.2(m)-.6(e)5.2(,)-318.5(wh)6.3(il)6.2(e)-317.4(s).8(e)5.2(v).6(er)6.4(al)-316.3(A)5.5(R)-.4(T)-317.4(p)6.3(ra)5.2(ct)6.2(ice)5.2(s)]TJ
T*
.0121 Tc
[(h)5.2(a)-1.7(v)5.2(e)-393.3(ch)5.2(an)5.2(ged,)-388.7(nat)5.1(u)-.5(r)5.3(a)-1.7(l)-392.3(c)4.1(ycle)-393.3(and)-392.2(c)4.1(lo)5.2(mi)5.1(ph)5.2(en)5.2(e)-393.3(c)-1.7(i)5.1(t)-.6(rate)-393.3(\()5.3(C)-1.5(C\))]TJ
T*
.0114 Tc
[(OI)-444.7(pr)4.6(oto)4.5(c)-2.4(o)4.5(l)-1.3(s)-444.5(h)4.5(av)4.5(e)-445.9(r)-1.2(emain)4.5(e)-2.4(d)-444.7(s)4.7(tandard)4.5(ized)4.5(.)-447(L)3.4(et)4.4(rozol)4.4(e)-445.9(w)-2.1(as)]TJ
0 -1.1174 TD
.0071 Tc
[(mo)-5.5(re)-329.2(c)-6.7(o).2(n)-5.5(s).4(i)-5.6(s)-5.3(te)-6.7(nt)-5.6(ly)-328.1(u)-5.5(s).4(e)-6.7(d)-328.1(fo)-5.5(r)-328(O)-.6(I)-328(s).4(t)-5.6(a)-6.7(rt)-5.6(in)-5.5(g)-328.1(i).1(n)-328.1(2)-5.5(01)-5.5(2.)-330.4(Th)-5.5(is)-327.9(s)-5.3(t).1(u)-5.5(d).2(y)]TJ
0 -1.1116 TD
.0118 Tc
[(was)-363.5(a)-2(pp)4.9(ro)4.9(ved)-369.4(b)4.9(y)-369.4(t)4.8(he)-370.6(I)5(c)-2(ahn)-363.7(S)-.7(cho)4.9(o)-.8(l)-369.6(o)4.9(f)-369.4(M)4(ed)4.9(icin)4.9(e)-370.6(a)3.8(t)-369.6(M)4(oun)4.9(t)]TJ
T*
.0115 Tc
[(S)4.8(i)-1.2(nai)-352.6(Ins)4.8(ti)4.5(tut)4.5(i)-1.2(o)4.6(n)-1.1(al)-358.3(Rev)4.6(i)-1.2(ew)-359.1(Board)-352.5(w)-2(it)4.5(h)-358.2(a)-353.6(waiv)4.6(er)-352.4(of)-352.4(pati)4.5(en)4.6(t)]TJ
0 -1.1174 TD
.0109 Tc
[(conse)-2.9(n)4(t.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 310.8472 615.855 Tm
0 Tc
[(Patient)-299.7(selection)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 599.4707 Tm
[(Lesbian)-460.4(and)-459.5(heterosexual)-467.2(women)-458(were)-462.6(included)-460.7(in)-463.1(the)]TJ
-1.0137 -1.1174 TD
[(study)-316.5(and)-321.2(identied)-323.5(through)-318.8(natural)-327.1(language)-317.7(processing)-324.1(of)]TJ
0 -1.1116 TD
[(electronic)-442.2(medical)-444.7(records.)-439.4(Women)-442.1(who)-441.9(self-identied)-445.2(as)]TJ
T*
[()50.8(lesbian)45.4()-335.1(o)0(r)-342(i)0(n)-336.4(a)-342.1()50.8(same-sex)-342.5(couple)47.5()-340.9(relationship)-344.1(were)-341.6(in-)]TJ
0 -1.1174 TD
[(cluded)-539(in)-538(the)-534.5()50.8(lesbian)-541.1(women)47.7()-536.7(group.)-538.8(Women)-534.3(without)]TJ
0 -1.1116 TD
[(these)-215.1(identiers)-214.9(and)-217.6(who)-211.5(had)-211.8(a)-215.4(known)-213.7(male)-215.4(partner)-217.4(in)-209.7(the)-217.7(da-)]TJ
T*
[(tabase)-361.4(were)-364.7(included)-362.7(in)-365.2(the)-361.7()50.8(heterosexual)-364.6(women)47.7()-363.9(group.)]TJ
0 -1.1174 TD
[(Women)-327(who)-326.7(identied)-323.5(as)-325.7()50.8(single,)44.2()-323.6(o)0(r)-324.7(a)0(s)-325.7(a)-324.8()50.8(single)-325.7(mother)]TJ
0 -1.1116 TD
[(by)-278.7(choice,)48.6()-283.3(o)0(r)-284.4(those)-277.3(who)-286.4(indicated)-284.5(a)-278.7(desire)-285.3(for)-279.7()50.8(single)-285.4(par-)]TJ
T*
[(enting,)50.8()-300.6(were)-307.1(excluded)-300.4(from)-299.3(the)-304.1(analysis.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 310.8472 478.8282 Tm
[(Natural)-303.2(cycle)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 462.3873 Tm
[(Patients)-224.3(undergoing)-219.6(natural)-223.4(cycle)-228(preparation)-223.1(for)-222.1(IUI)-223(were)]TJ
-1.0137 -1.1116 TD
[(monitored)-312(for)-308.5(the)-309.9(presence)-312.7(of)-307.4(a)-307.5(dominant)-311(follicle.)-314.6(Monitor-)]TJ
0 -1.1174 TD
[(ing)-406.6(was)-408.3(performed)-410.8(by)-405.4(transvagina)-9.9(l)-404.4(ultrasound)-409.6(starting)-413.3(be-)]TJ
0 -1.1116 TD
[(tween)-440.8(day)-442.2(10)-439.9(and)-436.4(14,)-443.4(depending)-438.6(on)-439.9(cycle)-441.1(length,)-443.4(until)-437.9(a)]TJ
T*
[(dominant)-437.7(follicle)-432.1(\()]TJ
/F7 1 Tf
7.8447 0 TD
()Tj
/F5 1 Tf
.5529 0 TD
[(18)-169.2(mm\))-431.9(was)-437.1(observed,)-440.6(at)-435.5(which)-433.9(point)]TJ
-8.3976 -1.1174 TD
[(ovulation)-391.6(was)-396.8(triggered)-398.3(with)-397.2(recombinant)-397.2(hCG)-391.1(\(Ovidr)-7.6(el)]TJ
/F7 1 Tf
7.3823 0 0 6.5614 541.3038 411.9873 Tm
()Tj
/F5 1 Tf
9.843 0 0 9.843 547.1432 407.5652 Tm
(;)Tj
-24.0065 -1.1116 TD
[(EMD)-369.1(Serono,)-373.9(Inc.,)-374.2(Rockland,)-372.8(MA\).)-371.3(Endometrial)-374.3(thickness)]TJ
T*
[(was)-212.5(also)-207.1(recorded)-213.8(at)-210.8(this)-211.8(cycle)-210.7(time)-208.6(point.)-210.8(IUI)-211.5(was)-212.5(performed)]TJ
T*
[(36)-301.7(hours)-299(after)-301.6(ovulation)-305.2(trigger)-302.8(was)-298.9(administered.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 310.8472 352.7432 Tm
[(OI)-297.4(with)-304.9(oral)-298.8(medications)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 336.3023 Tm
[(OI)-337.1(wa)13.1(s)-346.5(p)0(e)13.9(r)0(f)15.1(o)0(r)15.1(m)0(e)18.4(d)-352.4(wi)19.8(th)-342.1(CC)13(,)-343.3(a)-347.8(se)14.1(le)13.8(ct)13.8(iv)15(e)-347.8(e)0(s)14.1(t)0(r)15(o)0(g)15.1(e)0(n)-337.4(r)0(e)14(c)0(e)12.8(p)0(t)15(o)0(r)]TJ
-1.0137 -1.1174 TD
[(mo)19.6(du)15.1(la)13.8(to)15(r,)-332.8(or)-324.7(le)13.8(tr)15(oz)13.9(ol)14.9(e,)-328.2(a)-342.1(t)0(h)14.9(i)0(r)20.7(d)0(-)15.1(g)0(e)13.9(n)0(e)13.9(r)0(a)14(t)0(i)14.8(o)0(n)-330.5(a)0(r)14(o)0(m)19.6(a)0(t)13.8(a)0(s)14.1(e)-336.3(in)15(hi)14.9(bi)14.9(-)]TJ
0 -1.1116 TD
[(to)15(r.)-459.5(Th)13.9(e)-474.6(c)0(h)19.7(o)0(i)14.9(c)0(e)-465.3(o)0(f)-462.9(c)0(o)13.9(n)0(t)15(r)0(o)15.1(l)0(l)14.8(e)0(d)-464.1(o)0(v)15.1(a)0(r)13.9(i)0(a)13.8(n)-467.6(st)15.1(im)13.7(ul)14.9(at)13.8(io)15(n)-467.6(p)0(r)15.1(o)0(t)14.9(o)0(c)13.9(o)0(l)]TJ
T*
[(wa)13(s)-300.4(d)0(e)13.9(t)0(e)13.8(r)0(m)19.6(i)0(n)14.9(e)0(d)-297.1(b)0(y)-290.2(t)0(h)15(e)-301.8(tr)15(ea)12.8(ti)14.8(ng)-295.9(ph)20.8(ys)15.3(ic)13.8(ia)13.8(n.)-292.5(Ty)13.9(pi)14.9(ca)12.8(ll)14.8(y,)-292.5(wo)14.2(me)18.4(n)]TJ
T*
[(wi)14.1(th)-440.1(un)15.1(ex)13.9(pl)14.9(ai)19.5(ne)13.9(d)-450.3(i)0(n)15(f)0(e)14(r)0(t)15(i)0(l)14.8(i)0(t)14.8(y)-450.4(we)18.8(re)-446.8(st)15.1(ar)14(te)19.6(d)-450.4(o)0(n)-445.7(C)0(C)-442(a)0(n)13.9(d)-444.6(th)15(os)15.3(e)]TJ
0 -1.1174 TD
[(wi)14.1(th)-353.7(PC)14.2(OS)-354.3(we)13(re)-360.4(pl)20.7(ac)12.8(ed)-360.5(on)-353.5(le)13.8(tr)15(oz)13.9(ol)20.7(e;)-360.6(ho)15.1(we)13(ve)19.7(r,)-355.8(va)13.9(ri)15(at)13.8(io)15(n)-364(i)0(n)]TJ
0 -1.1116 TD
[(me)18.4(di)14.9(ca)12.8(ti)14.8(on)-313.2(ch)13.9(oi)14.9(ce)-315.5(wa)13(s)-323.4(b)0(a)13.9(s)0(e)14.1(d)-317.9(on)-319(ph)20.8(ys)15.3(ic)13.8(ia)13.8(n)-323.6(d)0(i)14.9(s)0(c)14.1(r)0(e)13.9(t)0(i)14.8(o)0(n)20.8(.)-326(Th)13.9(es)19.9(e)]TJ
T*
[(me)18.4(di)14.9(ca)12.8(ti)14.8(on)15.1(s)-340.7(w)0(e)18.8(r)0(e)-331.6(a)0(d)13.9(m)0(i)13.7(n)0(i)14.9(s)0(t)15.1(e)0(r)14(e)0(d)-331.7(s)0(t)15.1(a)0(r)14(t)0(i)20.6(n)0(g)-330.5(o)0(n)-330.5(c)0(y)13.9(c)0(l)13.8(e)-342.1(da)19.7(y)-340.9(3)-335.2(un)15.1(ti)14.8(l)]TJ
0 -1.1174 TD
[(cy)13.9(cl)19.5(e)-273(d)0(a)13.9(y)-271.8(7.)-263.7(In)15.1(it)14.8(ia)13.8(l)-271.9(d)0(o)15.1(s)0(e)14.1(s)-271.6(of)-261.4(10)15.1(0)-156.6(m)0(g)-268.4(o)0(f)-261.3(C)0(C)-263.5(a)0(n)13.9(d)-271.8(5)-162.4(m)0(g)-262.6(o)0(f)-261.4(l)0(e)13.8(t)0(r)15(o)0(-)]TJ
0 -1.1116 TD
[(zo)13.9(le)-216.6(we)18.8(re)-222.2(us)21(ed)-222.2(un)20.8(ti)14.8(l)-225.9(o)0(v)15.1(a)0(r)14(i)0(a)13.8(n)-220(re)14(sp)15.3(on)15.1(se)-216.3(wa)13(s)-225.5(o)0(b)20.8(s)0(e)14.1(r)0(v)15.1(e)0(d)13.9(.)-222.3(Mo)14.2(ni)14.9(to)14.9(r-)]TJ
T*
[(in)15(g)-490.7(b)0(y)-486(t)0(r)15(a)0(n)13.9(s)0(v)15.3(a)0(g)13.9(i)0(n)15(a)0(l)-487.3(u)0(l)14.9(t)0(r)15(a)0(s)14.1(o)0(u)20.8(n)0(d)-491.8(w)0(a)18.8(s)-496.2(pe)13.9(rf)15.1(or)15.1(me)18.4(d)-496.4(s)0(t)15.1(a)0(r)14(t)0(i)14.8(n)0(g)-486(o)0(n)]TJ
0 -1.1174 TD
[(cy)13.9(cl)19.5(e)-382.4(d)0(a)13.9(y)-375.5(11)-370.8(to)-370.9(12)-365.1(un)15.1(ti)14.8(l)-381.4(a)-376.6(do)15.1(mi)13.7(na)19.7(nt)-371(fo)15.1(ll)14.8(ic)13.8(le)-372.1(\()]TJ
/F7 1 Tf
18.7997 0 TD
()Tj
/F5 1 Tf
.5472 0 TD
[(18)-151.9(mm)18.4(\))-375.5(w)0(a)13(s)]TJ
-19.3469 -1.1116 TD
[(identi)-8.2(ed.)-353.3(If)-353.5(no)-353.5(respon)-7.5(se)-354.5(to)-353.7(oral)-351.2(medic)-9.2(ation)-358.3(was)-356.5(observ)-7.5(ed,)]TJ
T*
[(either)-567.8(the)-563.3(cycle)-567.8(was)-563.8(cance)-10.2(lled)-564.5(or)-560.9(additi)-8.2(onal)-570.1(medication)]TJ
T*
[(was)-345(admin)-8(istere)-9(d)-346.7(i)0(n)-347.9(a)-342.1(stair-s)-14.4(tep)-344.4(manne)-9.1(r,)-344.3(in)-347.9(which)-353.2(a)-342.1(higher)]TJ
0 -1.1174 TD
[(dose)-270.3(of)-272.9(the)-269.5(same)-272.7(medic)-9.2(ation)-277.6(was)-270.1(prescri)-9.9(bed)-269.4(in)-273(step-w)-8.5(ise)-269.3(in-)]TJ
0 -1.1116 TD
[(creme)-10.2(nts)-279.7(\(e.g.,)-285.4(CC)-280.7(100)-164.6(mg)-279.9(to)-284.6(150)-164.6(mg)-279.9(to)-284.6(200)-164.6(mg)-279.9(or)-284.4(letroz)-9.2(ole)]TJ
T*
[(5)-168.1(m)0(g)-326(t)0(o)-324.9(7.5)-166.9(mg\).)-330.5(Ovulat)-8.9(ion)-326(trigge)-8(r)-323.6(and)-327(IUI)-326.7(were)-335.9(performed)]TJ
0 -1.1174 TD
[(as)-302.7(descri)-8.8(bed)-304(in)-301.8(the)-304.1(natura)-9(l)-300.7(cycle)-308.6(protoc)-7.9(ol.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 310.8472 117.0141 Tm
[(Intrauterine)-297.6(insemination)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 100.6299 Tm
[(Previously)-225.2(cryopreserved)-231.8(sperm)-220.8(samples)-229.9(were)-226.4(thawed)-228.8(in)-227(a)]TJ
-1.0137 -1.1174 TD
[(37-degree)-387.7(incubator)-386.8(for)-383.4(15)-382.3(minutes)-390.3(on)-382.3(the)-384.7(morning)-383.4(of)-388.1(the)]TJ
0 -1.1116 TD
[(scheduled)-295.6(IUI.)-295.5(Samples)-299(were)-301.3(then)-293.7(homogenized)-299.2(thoroughly)]TJ
T*
[(with)-368.4(a)-376.6(large)-370.8(volume)-372(pipette)-373.3(and)-373.1(the)-373.2(volume)-372(of)-370.8(the)-367.5(sample)]TJ
0 -1.1174 TD
[(and)-401.9(spermatozo)-9.9(a)-399.7(count)-410(was)-402.6(recorded.)-413.1(Sperm)-405.1(wash)-403.7(\(Irvine)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.5368 Tm
[(UNDERSTANDING)-308.8(THE)-303.5(LESBIAN)-304.3(REPRODUCTIVE)-302.5(EXPERIENCE)-22856.8(63)]TJ
ET
endstream
endobj
33 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 725.5557 Tm
0 0 0 rg
0 Tc
0 Tw
[(Scientic,)-293.4(Santa)-295.8(Ana,)-291(CA\))-293.2(was)-293.1(then)-287.9(added)-295.8(to)-290.3(twice)-291.2(the)-292.6(vol-)]TJ
0 -1.1174 TD
[(ume)-345.5(of)-342(the)-338.7(sample)-344.2(and)-344.3(the)-344.4(sample)-344.2(was)-339.2(mixed.)-345.5(The)-345.5(sample)]TJ
0 -1.1116 TD
[(was)-448.6(then)-449.2(centrifuged)-453.5(at)-447(300)-446.8(times)-451.5(gravity,)-450.3(approximately)]TJ
T*
[(1500)-240.6(revolutions)-243.8(per)-240.6(minute)-245.4(for)-239.4(10)-244.1(minutes.)-238.2(The)-247.6(supernatant)]TJ
T*
[(was)-281.6(then)-276.4(removed)-276.2(and)-280.9(the)-275.3(pellet)-280(was)-275.8(resuspended)-285.9(in)-273(0.3)-166.9(mL)]TJ
0 -1.1174 TD
[(of)-301.7(sperm)-301.4(wash)-300(media)-302.9(and)-304(mixed.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 644.4282 Tm
[(Outcome)-299.2(measures)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 627.9872 Tm
[(Data)-485.8(were)-491.4(collected)-487.2(regarding)-490.4(the)-488.4(patient)-488.5(reproductive)]TJ
-1.0137 -1.1116 TD
[(journey,)-490.5(including)-489.5(diagnostic)-491.6(procedures)-492.3(and)-488.3(the)-488.4(number)]TJ
0 -1.1174 TD
[(and)-419.2(type)-420.4(of)-422.6(cycles)-419(each)-422.6(patient)-425.1(underwent.)-419.8(Patient)-425(demo-)]TJ
0 -1.1116 TD
[(graphics)-316.3(and)-315.5(baseline)-317.6(characteristics)-323.1(that)-316.9(were)-312.8(collected)-320.2(in-)]TJ
T*
[(cluded)-377.7(age,)-383.4(body)-373(mass)-380.8(index)-381.2(\(BMI\),)-379.4(gravidity,)-377.7(parity,)-380.1(and)]TJ
0 -1.1174 TD
[(ma)18.4(rk)20.9(er)19.7(s)-346.5(o)0(f)-336.2(o)0(v)20.8(a)0(r)19.7(i)0(a)19.6(n)-346.7(re)19.7(se)19.9(rv)20.9(e)-347.8(\()0(a)19.7(n)0(t)20.7(i)0(-)20.7(M)0(u)]TJ
14.2322 .0115 TD
()Tj
.4089 -.0115 TD
[(ll)20.6(er)19.7(ia)19.6(n)-346.7(h)0(o)20.8(r)0(m)19.6(o)0(n)20.8(e)-342.1([A)14.2(MH)19.1(])]TJ
-14.6412 -1.1116 TD
[(le)19.5(ve)19.7(l,)-442.4(da)19.7(y)-450.3(3)-450.4(fo)20.9(ll)20.6(ic)19.6(le)19.6(-s)15.3(ti)20.6(mu)19.6(la)19.6(ti)20.6(ng)-439.9(ho)20.8(rm)19.6(on)15.1(e)-445.8([)0(F)15.3(S)0(H)20.1(])-450.3(le)19.6(ve)19.7(l,)-442.4(an)19.7(d)]TJ
T*
[(ba)19.7(sa)19.9(l)-237.4(a)0(n)19.7(t)0(r)15(a)0(l)-228.1(f)0(o)20.9(l)0(l)20.6(i)0(c)19.5(l)0(e)-228.1(c)0(o)19.7(u)0(n)20.8(t)-237.4([B)19.8(AF)14.4(C])19.8(\).)-223.4(Se)14.1(ve)19.7(ra)19.7(l)-237.4(c)0(y)19.7(c)0(l)19.5(e)-238.4(ch)19.7(ar)19.7(ac)18.5(te)19.6(ri)15(s-)]TJ
T*
[(ti)20.6(cs)-199(we)18.8(re)-193.4(al)19.5(so)-197.8(de)19.7(te)19.6(rm)19.6(in)20.7(ed)19.7(,)-205(i)0(n)20.7(c)0(l)19.6(u)0(d)20.8(i)0(n)15(g)-202.7(th)20.7(e)-203.8(n)0(u)20.8(m)0(b)19.6(e)0(r)-199.2(o)0(f)-192.2(m)0(a)18.4(t)0(u)20.7(r)0(e)-193.4(f)0(o)15.1(l)0(-)]TJ
0 -1.1174 TD
[(li)20.6(cl)19.6(es)-319.9(an)19.7(d)-329.4(t)0(h)20.7(e)-330.6(en)19.7(do)20.8(me)18.4(tr)20.7(ia)13.8(l)-323.8(t)0(h)20.7(i)0(c)13.8(k)0(n)20.8(e)0(s)19.9(s)-329.2(at)-320.3(th)20.7(e)-324.8(t)0(i)14.8(m)0(e)-315.6(o)0(f)-319(o)0(v)20.8(u)0(l)20.7(a)0(t)19.5(o)0(r)15.1(y)]TJ
0 -1.1116 TD
[(su)21(rg)15.1(e)-319(a)0(n)19.7(d)-317.9(SA)-308.2(pa)19.7(ra)14(me)18.4(te)19.6(rs)21.1(,)-320.2(s)0(p)21(e)0(c)18.5(i)0()20.9(c)0(a)12.8(l)0(l)20.6(y)-317.9(th)20.7(e)-319(t)0(o)20.7(t)0(a)13.8(l)-318(mo)19.6(ti)20.6(le)-308.8(sp)15.3(er)19.7(m)]TJ
T*
[(co)19.7(un)20.8(t)-295(\()0(T)19.7(M)0(S)20.1(C)0(\))19.8(.)]TJ
1.0137 -1.1174 TD
[(The)-426.1(primary)-430.6(outcome)-431.9(of)-428.4(interest)-431.8(was)-431.4(the)-425.1(clinical)-433.3(preg-)]TJ
-1.0137 -1.1116 TD
[(nancy)-318.9(\(CP\))-316.2(rate,)-321.3(which)-318.7(was)-316.2(conrmed)-323.2(by)-313.2(the)-321.4(presence)-318.5(of)-318.9(a)]TJ
T*
[(gestational)-407.6(sac)-408.6(on)-405.4(transvaginal)-408.5(ultrasound.)-407.3(Secondary)-404.9(out-)]TJ
0 -1.1174 TD
[(comes)-314.1(included)-310.9(ongoing)-313.1(pregnancy/live)-314.2(birth)-311(\(OP/LB\))-316(rate,)]TJ
0 -1.1116 TD
[(early)-537.8(pregnancy)-537.5(loss)-539.8(\(EPL\))-537.6(rate,)-534.4(and)-540.1(clinical)-537(pregnancy)]TJ
T*
[(loss)-315.2(\(CPL\))-312.8(rate.)-309.8(An)-314.1(OP)-313.9(was)-310.4(dened)-314(as)-314.2(a)-313.3(viable)-308.7(intrauterine)]TJ
0 -1.1174 TD
[(gestation)-358(at)-354.8(the)-350.2(time)-358.4(of)-347.7(discharge)-358.9(from)-356.9(the)-350.2(practice,)-356.9(which)]TJ
0 -1.1116 TD
[(occurred)-225.3(no)-221.1(earlier)-224.5(than)-224.6(8)-220(weeks)-227.4(of)-221(gestation.)-223.2(A)-220.8(L)0(B)-223.3(was)-224(con-)]TJ
T*
[(sidered)-344(the)-338.7(delivery)-339.7(of)-342(a)-336.3(live)-339.9(born)-344.2(infant)-336.3(after)-342(24)-342(weeks)-342.6(of)]TJ
T*
[(gestation.)-424.8(EPL)-420.2(was)-419.8(dened)-423.5(as)-423.6(a)-417(loss)-424.6(following)-420.1(a)-422.7(positive)]TJ
0 -1.1174 TD
[(pregnancy)-428.1(test)-420.3(and)-424.9(before)-423.6(the)-419.3(detection)-428.5(of)-422.6(an)-418.1(intrauterine)]TJ
0 -1.1116 TD
[(gestational)-263.6(sac)-258.9(on)-255.6(ultrasound.)-257.6(CPL)-258.8(was)-258.6(dened)-256.4(as)-256.6(a)-255.7(loss)-257.6(fol-)]TJ
T*
[(lowing)-307.2(a)-307.5(positive)-303.9(pregnancy)-312.9(test)-305.1(and)-304(the)-309.9(detection)-307.5(of)-301.7(an)-308.6(in-)]TJ
25.504 36.6317 TD
[(trauterine)-314.3(gestational)-315.4(sac)-310.7(on)-307.5(ultrasound.)-309.4(Multiple)-316.7(gestations)]TJ
0 -1.1174 TD
[(were)-364.7(dened)-360.1(by)-359.3(the)-361.7(presence)-358.8(of)-359.3(more)-363.9(than)-357(one)-361.6(gestational)]TJ
0 -1.1116 TD
[(sac)-304.9(on)-301.7(transvaginal)-304.9(ultrasound.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 313.0582 681.6754 Tm
[(Statistical)-304.5(analyses)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 665.2345 Tm
[(Demographic)-398(and)-390.4(cycle)-395(characteristics,)-401.4(as)-389.1(well)-392.6(as)-394.8(preg-)]TJ
-1.0137 -1.1116 TD
[(nancy)-503.2(outcomes)-501.9(were)-502.9(compared)-497.3(using)-500.8(a)-497.6(Students)]TJ
/F6 1 Tf
22.0309 0 TD
(t)Tj
/F5 1 Tf
.2822 0 TD
(-test,)Tj
-22.3131 -1.1174 TD
[(Fishers)-625.8(exact)-625.4(test,)-619.6(and)-626.5(chi-squared)-620.2(test.)-625.4(A)]TJ
/F6 1 Tf
19.8307 0 TD
(p)Tj
/F5 1 Tf
.4953 0 TD
[(-value)-625.3(of)]TJ
/F7 1 Tf
-20.326 -1.1116 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(0.05)-409.9(was)-414.1(considered)-417.6(signicant.)-414.2(To)-406.6(assess)-417.1(differences)-414(in)]TJ
-.5529 -1.1116 TD
[(clinical)-249(outcomes,)-240.4(a)-238.4(multivariate)-243.2(logistic)-246.4(regression)-243.4(was)-241.3(per-)]TJ
0 -1.1174 TD
[(forme)-7.8(d)-289.1(for)-291.2(each)-295.9(outcome)-299.4(\(CP,)-289.8(OP/LB,)-300(EPL,)-291.2(and)-292.5(CPL)-293.4(rate\).)]TJ
0 -1.1116 TD
[(Model)-7.7(s)-260.1(were)-266.8(adjusted)-264.6(for)-262.4(covariates,)-272.6(including)-264.9(age,)-262.5(markers)]TJ
T*
[(of)-284.4(ovarian)-280.8(reserve,)-279.3(number)-285.4(of)-278.6(mature)-281(follicles)-283.2(at)-280(the)-281.1(time)-277.8(of)]TJ
0 -1.1174 TD
[(surge,)-315.1(parity,)-305.2(and)-309.7(TMSC)-312.6(on)-307.5(SA.)-305.9(Likelihood)-313.3(of)-307.4(clinical)-312.3(out-)]TJ
0 -1.1116 TD
[(come)-8(s)-375.3(was)-373.8(presented)-381.9(as)-377.5(odds)-378.6(ratios)-376.4(\(OR\))-374.9(with)-379.9(95%)-378.7(con-)]TJ
T*
[(dence)-475.5(intervals)-467.4(\(CIs\).)-470.5(All)-465.2(analyses)-472.8(were)-468.3(conducted)-474.3(using)]TJ
T*
[(SAS)-303.4(software)-305.6(\(SAS)-298.7(Institute)-305.1(Inc.,)-299.3(Cary,)-303.7(NC\).)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 313.0582 522.1983 Tm
(Results)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 505.7573 Tm
[(A)-318.7(total)-318.1(of)-313.2(216)-314.3(lesbian)-321.1(women)-314(underwent)-324.2(451)-314.3(natural)-315.5(cy-)]TJ
-1.0137 -1.1116 TD
[(cles)-317.7(and)-309.7(441)-308.6(OI)-314.1(cycles.)-313(A)-307.2(total)-312.3(of)-313.2(584)-308.6(heterosexual)-317.4(women)]TJ
T*
[(underwent)-364.6(1177)-355.7(natural)-361.6(cycles)-361.4(and)-355.8(1238)-361.5(OI)-354.4(cycles.)-364.8(Of)-354.4(the)]TJ
T*
[(lesbian)-413.3(patients)-414.5(who)-413.1(underwent)-410.6(IUI)-413.1(cycles,)-410.9(64)-411.1(\(30%\))-409.7(had)]TJ
0 -1.1174 TD
[(an)-308.6(HSG)-310.2(as)-308.4(part)-305.2(of)-307.4(their)-312.2(initial)-309(workup.)-304.6(The)-310.9(majority)-311.1(of)-301.7(les-)]TJ
0 -1.1116 TD
[(bian)-218.8(women)-216.1(who)-217.3(underwent)-214.8(a)-215.4(diagnostic)-220.9(HSG)-212.2(had)-217.6(a)-215.4(risk)-217.4(fac-)]TJ
T*
[(tor)-487.2(for)-481.3(tubal)-485(disease)-489(or)-486(had)-482.5(a)-486.1(hydrosalpinx)-486.7(identied)-484.8(on)]TJ
0 -1.1174 TD
[(ultrasound.)-436.1(Among)-428.1(heterosexual)-432.6(patients,)-429.5(64%)-430.6(of)-428.4(patients)]TJ
0 -1.1116 TD
[(undergoing)-380.9(natural)-378.9(cycles)-372.9(and)-378.8(81%)-373(of)-376.5(patients)-380(undergoing)]TJ
T*
[(OI)-388.9(cycles)-384.4(had)-390.4(an)-383.5(HSG)-385(as)-383.3(part)-385.8(of)-388.1(their)-381.3(diagnostic)-387.9(workup.)]TJ
0 -1.1174 TD
[(Of)-371.7(lesbian)-367.2(women)-365.9(who)-367(underwent)-370.3(OI,)-369.3(approximately)-365(40%)]TJ
ET
313.058 354.954 239.131 .22675 re
f
313.058 58.45 239.131 .22675 re
f
313.058 306.368 239.131 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 334.4881 371.5652 Tm
(Table)Tj
/F5 1 Tf
2.9656 0 TD
(2.)Tj
/F9 1 Tf
1.2496 0 TD
[(Lesbian)-302.8(and)-303.2(Heterosexual)-301.1(Women)]TJ
-3.6912 -1.0135 TD
[(Undergoing)-300.4(Ovulation)-305.4(Induction)-300.2(Cycles)]TJ
/F6 1 Tf
7.4228 -1.9406 TD
(Lesbian)Tj
.167 -1.0135 TD
(women)Tj
-.3628 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(441\))Tj
3.219 2.027 TD
(Heterosexual)Tj
1.2554 -1.0135 TD
(women)Tj
-.6104 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(1238\))Tj
/F5 1 Tf
5.1539 -1.0077 TD
(p)Tj
/F6 1 Tf
-12.8761 0 TD
(Mean)Tj
/F7 1 Tf
2.4474 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
[(SD)-1448.2(Mean)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F6 1 Tf
.7141 0 TD
(SD)Tj
/F5 1 Tf
-18.5137 -1.9003 TD
[(Age)-304.4(\(years\))-4765.7(36.2)]TJ
/F7 1 Tf
11.4307 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(4.0)-1951.7(38.4)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
(4.6)Tj
/F7 1 Tf
3.006 0 TD
(<)Tj
/F5 1 Tf
.5471 0 TD
(0.0001)Tj
-21.537 -1.0135 TD
[(Body)-304.4(mass)-299.6(index)]TJ
.9962 -1.0077 TD
(\(kg/m)Tj
7.3837 0 0 6.5625 346.4503 278.3621 Tm
(2)Tj
9.845 0 0 9.845 350.1353 273.9968 Tm
(\))Tj
5.747 1.0077 TD
(26.3)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(5.7)-1951.7(26.1)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(5.7)-2303(0.74)]TJ
-17.9839 -2.0213 TD
[(Day)-304.4(3)-300.4(follicle-)]TJ
.9962 -1.0135 TD
(stimulating)Tj
0 -1.0077 TD
[(hormone)-297.2(\(ng/mL\))]TJ
8.5169 2.0212 TD
(7.31)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(2.9)-2452.7(8.3)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
(3.8)Tj
/F7 1 Tf
3.006 0 TD
(<)Tj
/F5 1 Tf
.5471 0 TD
(0.0001)Tj
-21.537 -3.0347 TD
(Anti-Mu)Tj
3.0866 .0115 TD
()Tj
.4146 -.0115 TD
(llerian)Tj
-2.505 -1.0135 TD
[(hormone)-297.2(\(ng/dL\))]TJ
9.0179 1.0135 TD
(4.1)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(4.1)-2452.7(2.5)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
(2.8)Tj
/F7 1 Tf
3.006 0 TD
(<)Tj
/F5 1 Tf
.5471 0 TD
(0.0001)Tj
-21.537 -2.027 TD
[(Basal)-307.7(antral)-302.3(follicle)]TJ
.9962 -1.0077 TD
(count)Tj
8.5169 1.0077 TD
(15.5)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(7.3)-1951.7(13.7)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(7.6)-2303(0.42)]TJ
-17.9839 -2.0212 TD
[(Number)-302.8(of)-301.4(mature)]TJ
.9962 -1.0135 TD
[(follicles)-299.7(at)-302.8(the)]TJ
T*
[(time)-300.3(of)-301.4(surge)]TJ
9.0179 2.027 TD
(1.6)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(0.9)-2452.7(1.7)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.9)-2303(0.03)]TJ
-17.9839 -3.0348 TD
(Endometrial)Tj
.9962 -1.0135 TD
(thickness)Tj
T*
[(at)-297(the)-303.8(time)-300.3(of)]TJ
0 -1.0077 TD
[(surge)-299.6(\(mm\))]TJ
9.0179 3.0347 TD
(8.7)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(1.8)-2452.7(8.4)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.6)-2303(0.0003)]TJ
-17.9839 -4.0483 TD
[(Gravidity)-5672.1(0.50)]TJ
/F7 1 Tf
11.4307 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(0.7)-1951.7(0.75)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.0)-2303(0.0001)]TJ
-17.9839 -1.0135 TD
[(Parity)-7119.1(0.16)]TJ
/F7 1 Tf
11.4307 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(0.6)-1951.7(0.21)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.5)-2303(0.30)]TJ
-17.9839 -1.0135 TD
[(Total)-307.1(motile)-296.7(sperm)]TJ
.9962 -1.0077 TD
[(count)-300(\(millions)]TJ
0 -1.0135 TD
[(of)-295.7(sperm\))]TJ
8.5169 2.0212 TD
(47.3)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(13.1)-1451.7(48.6)]TJ
/F7 1 Tf
5.1193 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(15.2)-1803(0.08)]TJ
-17.9839 -3.0348 TD
[(Clomid)-302.1(use)-303.4(\(%,)]TJ
/F6 1 Tf
6.6626 0 TD
(n)Tj
/F5 1 Tf
.501 0 TD
[(\))-2914.8(62.6%)]TJ
2.5683 -1.0135 TD
(\(276/441\))Tj
6.5187 1.0135 TD
(65.1%)Tj
-.9329 -1.0135 TD
(\(806/1238\))Tj
6.2192 1.0135 TD
(0.34)Tj
ET
62.022 323.716 239.131 .22678 re
f
62.022 57.09 239.131 .28345 re
f
62.022 275.131 239.131 .22678 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 83.4519 340.3275 Tm
(Table)Tj
/F5 1 Tf
2.9656 0 TD
(1.)Tj
/F9 1 Tf
1.2496 0 TD
[(Lesbian)-302.8(and)-297.5(Heterosexual)-301.1(Women)]TJ
-.7889 -1.0135 TD
[(Undergoing)-306.2(Natural)-296.5(Cycles)]TJ
/F6 1 Tf
4.7162 -1.9406 TD
(Lesbian)Tj
.167 -1.0135 TD
(women)Tj
-.3628 -1.0077 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(451\))Tj
3.0232 2.0213 TD
(Heterosexual)Tj
1.2554 -1.0135 TD
(women)Tj
-.6104 -1.0077 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7141 0 TD
(1177\))Tj
/F5 1 Tf
5.1539 -1.0135 TD
(p)Tj
/F6 1 Tf
-12.6746 0 TD
(Mean)Tj
/F7 1 Tf
2.4474 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
[(SD)-1252.4(Mean)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
(SD)Tj
/F5 1 Tf
-18.5137 -1.9003 TD
[(Age)-304.4(\(years\))-4961.5(36.1)]TJ
/F7 1 Tf
11.6265 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(3.8)-1750.2(39.3)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
(4.7)Tj
/F7 1 Tf
3.0002 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.0001)Tj
-21.537 -1.0077 TD
[(Body)-298.6(mass)-305.4(index)]TJ
.9905 -1.0135 TD
(\(kg/m)Tj
7.3837 0 0 6.5625 95.3575 247.1244 Tm
(2)Tj
9.845 0 0 9.845 99.0992 242.759 Tm
(\))Tj
5.9428 1.0135 TD
(24.6)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(5.7)-1750.2(25.7)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(5.2)-2303(0.004)]TJ
-17.9839 -2.027 TD
[(Day)-304.4(3)-300.4(follicle-)]TJ
.9905 -1.0135 TD
(stimulating)Tj
0 -1.0077 TD
[(hormone)-302.9(\(ng/mL\))]TJ
9.2194 2.0212 TD
(8.1)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(4.8)-2251.2(8.0)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(4.0)-2303(0.79)]TJ
-17.9839 -3.0347 TD
(Anti-Mu)Tj
3.0866 .0115 TD
()Tj
.4146 -.0115 TD
(llerian)Tj
-2.5107 -1.0135 TD
[(hormone)-302.9(\(ng/dL\))]TJ
9.2194 1.0135 TD
(4.0)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(2.8)-2251.2(2.1)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.7)-2303(0.002)]TJ
-17.9839 -2.0212 TD
[(Basal)-302(antral)-302.3(follicle)]TJ
.9905 -1.0135 TD
(count)Tj
9.467 1.0135 TD
(19)Tj
/F7 1 Tf
1.169 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(3.6)-1750.2(14.6)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(5.4)-2303(0.24)]TJ
-17.9839 -2.027 TD
[(Number)-302.8(of)-301.4(mature)]TJ
.9905 -1.0135 TD
[(follicles)-305.5(at)-302.8(the)]TJ
0 -1.0077 TD
[(time)-306.1(of)-295.7(surge)]TJ
8.7184 2.0212 TD
(0.96)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.3)-1750.2(0.95)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.4)-2303(0.66)]TJ
-17.9839 -3.0348 TD
[(Endometrial)-304(thickness)]TJ
.9905 -1.0135 TD
[(at)-302.8(the)-303.8(time)-300.3(of)]TJ
T*
[(surge)-305.4(\(mm\))]TJ
9.2194 2.027 TD
(9.1)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.7)-2251.2(8.9)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.7)-2303(0.03)]TJ
-17.9839 -3.0348 TD
[(Gravidity)-5867.9(0.41)]TJ
/F7 1 Tf
11.6265 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.8)-1750.2(0.73)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.1)-2303(0.0006)]TJ
-17.9839 -1.0135 TD
[(Parity)-7314.9(0.11)]TJ
/F7 1 Tf
11.6265 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.5)-1750.2(0.24)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.5)-2303(0.0003)]TJ
-17.9839 -1.0135 TD
[(Total)-301.3(motile)-302.5(sperm)]TJ
.9905 -1.0077 TD
[(count)-300(\(millions)]TJ
0 -1.0135 TD
[(of)-301.4(sperm\))]TJ
8.7184 2.0212 TD
(46.8)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(12.2)-1250.2(45.1)]TJ
/F7 1 Tf
4.9178 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(14.1)-1803(0.02)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.5368 Tm
(64)Tj
47.6178 0 TD
[(NAZEM)-308(ET)-300.7(AL.)]TJ
ET
endstream
endobj
39 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 407.5085 Tm
0 0 0 rg
0 Tc
0 Tw
[(had)-442.2(undergone)-438.4(at)-435.5(least)-445.6(one)-436.4(prior)-437.5(natural/IUI)-441.8(cycle)-441.1(\(range)]TJ
0 -1.1116 TD
[(111)-303.9(cycles\).)]TJ
1.0137 -1.1174 TD
[(Demographic)-219.4(and)-211.8(cycle)-216.5(characteristics)-219.4(of)-215.3(patients)-212.9(who)-211.5(un-)]TJ
-1.0137 -1.1116 TD
[(derwent)-339.3(natural)-338.6(and)-338.5(OI)-337.1(cycles)-338.3(are)-339.7(listed)-342(in)-336.4(Tables)-338.4(1)-335.2(and)-338.5(2,)]TJ
T*
-.0162 Tc
[(resp)5.7(ect)5.6(ively.)-359.4(Lesb)5.7(ian)-357.1(w)-.9(o)5.7(men)-357.1(un)5.7(der)5.8(goin)5.7(g)-362.9(n)5.7(a)-1.2(tu)5.7(ral)-357.3(c)-1.2(y)5.7(c)-1.2(les)-362.7(w)4.9(ere)]TJ
0 -1.1174 TD
-.0164 Tc
[(you)5.5(nger)-305.5(\()5.6(36.1)]TJ
/F7 1 Tf
5.6272 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0172 Tc
[(3.8)-306.3(v)-1(s.)-302.9(39.3)]TJ
/F7 1 Tf
4.7402 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0174 Tc
[(4.7)-306.5(y)-1.2(ears,)]TJ
/F6 1 Tf
4.0664 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(<)Tj
/F5 1 Tf
.7027 0 TD
-.0162 Tc
[(0)5.7(.)-2.3(0)5.7(001)5.7(\))-305.2(a)-1.2(nd)-305.3(h)5.7(a)-1.2(d)-305.3(a)]TJ
-17.1812 -1.1116 TD
-.0179 Tc
[(lower)-353(B)-2.7(MI)-353(\(2)4(4.6)]TJ
/F7 1 Tf
6.8886 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.017 Tc
[(5)4.9(.)-3.1(7)-346.4(v)-.8(s.)-348.7(25.7)]TJ
/F7 1 Tf
4.8266 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0179 Tc
[(5.2)-168.7(k)-1.7(g)4(/)-1.8(m)]TJ
7.3823 0 0 6.5614 221.896 346.1101 Tm
0 Tc
(2)Tj
9.843 0 0 9.843 225.4109 341.7448 Tm
(,)Tj
/F6 1 Tf
.5817 0 TD
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0163 Tc
[(0.004)5.6(\),)-353.8(h)5.6(i)-.2(gh)5.6(er)]TJ
-18.7594 -1.1116 TD
-.0165 Tc
[(ovarian)-386.2(reserve)-393.1(\()5.5(AMH)-387.1(4.0)]TJ
/F7 1 Tf
10.7822 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0219 Tc
[(2.)-8(8)-397.4(v)0(s)-5.5(.)-399.7(2.)-8(1)]TJ
/F7 1 Tf
4.4235 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0171 Tc
(1.7,)Tj
/F6 1 Tf
1.8201 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0171 Tc
[(0.002)4.8(\),)-394.9(and)]TJ
-19.7788 -1.1174 TD
-.016 Tc
[(lower)-224.4(g)5.9(ravi)5.8(dit)5.8(y)-224.4(\(0)5.9(.4)5.9(1)]TJ
/F7 1 Tf
8.2652 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0168 Tc
[(0)5.1(.)-2.9(8)-219.5(v)-.6(s.)-221.8(0.73)]TJ
/F7 1 Tf
4.5674 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0171 Tc
(1.1,)Tj
/F6 1 Tf
1.653 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0168 Tc
[(0.000)5.1(6\))-225.2(and)-225.2(p)5.1(ari)5(t)-.8(y)]TJ
-17.2388 -1.1116 TD
(\(0.11)Tj
/F7 1 Tf
2.1599 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0219 Tc
[(0)-5.7(.)-2.3(5)-224.6(v)-5.7(s)-5.5(.)-226.9(0.)-8(24)]TJ
/F7 1 Tf
4.5674 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0219 Tc
[(0.)-8(5,)]TJ
/F6 1 Tf
1.6473 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0171 Tc
[(0.0003)4.8(\))-225.5(c)3.7(ompared)-219.8(w)-1.8(it)4.7(h)-225.5(h)4.8(eterosex-)]TJ
-11.1278 -1.1116 TD
-.0156 Tc
[(ual)-356.6(w)5.5(ome)5.2(n)-356.5(wh)6.3(o)-356.5(und)6.3(erwe)5.2(nt)-356.6(a)-357.7(n)6.3(atu)6.3(r).6(al)-356.6(c)5.2(y).6(cl)6.2(es.)-353.1(Les)6.5(bia)5.2(n)-356.5(wom)5.1(e)-.6(n)]TJ
T*
-.017 Tc
[(also)-490.4(had)-496.1(a)-491.6(th)4.9(icker)-496.1(e)3.8(ndo)4.9(met)4.8(rial)-496.3(l)4.8(i)-.9(nin)4.9(g)-496.2(at)-496.3(t)4.8(h)-.8(e)-497.3(t)4.8(ime)-497.3(o)-.8(f)-490.4(s)-.6(u)4.9(rge)]TJ
0 -1.1174 TD
-.0173 Tc
(\(9.1)Tj
/F7 1 Tf
1.6818 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0172 Tc
[(1.7)-404.2(v)4.7(s.)-400.8(8)4.7(.)-3.3(9)]TJ
/F7 1 Tf
4.4407 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0165 Tc
[(1.7)-167.3(m)4.2(m,)]TJ
/F6 1 Tf
3.5192 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.7027 0 TD
-.0217 Tc
[(0.)-7.9(03)-5.5(\))-402.9(a)-6.7(n)-5.5(d)-402.9(a)-404.1(h).2(i)-5.6(g)-5.5(he)-6.7(r)-402.9(T)-6.7(MS)-5.4(C)-404(o)-5.5(n)]TJ
-12.3949 -1.1116 TD
-.0156 Tc
[(SA)-368.9(\(46)6.3(.8)]TJ
/F7 1 Tf
3.7668 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0161 Tc
[(12)5.8(.2)-368.5(vs)6(.)-370.9(45.1)]TJ
/F7 1 Tf
5.3508 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0169 Tc
(14.1,)Tj
/F6 1 Tf
2.2866 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6451 0 TD
(=)Tj
/F5 1 Tf
.7027 0 TD
-.0166 Tc
[(0.02)5.3(\))-369(c)-1.6(ompar)5.4(e)-1.6(d)-369(w)-1.3(it)5.2(h)-374.8(h)5.3(et-)]TJ
-14.1516 -1.1116 TD
-.0163 Tc
[(ero)5.6(s).1(exu)5.6(a)-1.3(l)-484.1(w)-1(o)5.6(men)5.6(.)-486.3(T)-1.3(h)5.6(e)-1.3(re)-485.1(were)-485.1(no)-483.9(s)5.8(i)-.2(gni)5.5(cant)-484.1(d)-.1(if)5.7(fer)5.7(e)-1.3(nces)-483.7(in)]TJ
0 -1.1174 TD
-.0172 Tc
[(day)-386.9(3)-386.9(FSH,)-389.2(B)-2(AFC,)-383.5(or)-386.9(the)-388.1(n)-1(u)4.7(m)-2.2(b)4.7(e)-2.2(r)-386.9(o)-1(f)-386.9(m)-2.2(ature)-388.1(f)4.8(o)-1(lli)4.6(cles)-392.5(at)-387(the)]TJ
0 -1.1116 TD
-.0164 Tc
[(time)-300.9(o)-.2(f)-299.7(s)5.7(urge)-295.1(amo)5.5(ng)-299.7(g)5.5(roup)5.5(s)-299.5(und)5.5(erg)5.5(o)-.2(in)5.5(g)-299.7(n)-.2(at)5.4(ural)-299.9(c)-1.4(ycles)5.7(.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Among)-497.2(patients)-500.9(undergoing)-501.9(OI)-498.4(cycles,)-503(lesbian)-499.7(women)]TJ
-1.0137 -1.1174 TD
[(were)-502.9(younger)-498.4(\(36.2)]TJ
/F7 1 Tf
8.4783 0 TD
()Tj
/F5 1 Tf
.72 0 TD
[(4.0)-495.2(vs.)-500.8(38.4)]TJ
/F7 1 Tf
5.2989 0 TD
()Tj
/F5 1 Tf
.7142 0 TD
[(4.6)-501(years,)]TJ
/F6 1 Tf
4.6135 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(<)Tj
/F5 1 Tf
.7142 0 TD
(0.0001\))Tj
-21.2072 -1.1116 TD
-.0159 Tc
[(a)-15.9(n)9.5(d)-322.3(h).3(ad)-328(lowe)-15.9(r)-313(gra)-15.9(v)9.5(i).2(di)-15.9(t)10.4(y)-322.3(\(0)-15.9(.)14.1(5)-15.9(0)]TJ
/F7 1 Tf
11.9744 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
-.0154 Tc
[(0.7)-321.8(v)-15.4(s)11.4(.)-324.1(0.75)]TJ
/F7 1 Tf
4.7978 0 TD
0 Tc
()Tj
/F5 1 Tf
.7027 0 TD
[(1.)30(0)]TJ
/F6 1 Tf
1.5321 0 TD
(p)Tj
/F7 1 Tf
.6508 0 TD
(=)Tj
/F5 1 Tf
.7027 0 TD
-.0159 Tc
[(0.00)-15.9(0)10.7(1\),)]TJ
-21.0632 -1.1116 TD
.0246 Tc
[(h)-5.3(i).3(gher)-667.6(ovaria)-6.5(n)-661.9(res)-5.1(e)-.7(rve)-663.1(\()-5.3(AMH)-662.8(4.1)]TJ
/F7 1 Tf
15.8738 0 TD
0 Tc
()Tj
/F5 1 Tf
.743 0 TD
.0299 Tc
[(4.)9.2(1)-662.4(v)5.8(s)6(.)-658.9(2)5.8(.)3.4(5)]TJ
/F7 1 Tf
5.3565 0 TD
0 Tc
()Tj
/F5 1 Tf
.743 0 TD
.0247 Tc
(2.8,)Tj
/F6 1 Tf
-22.7163 -1.1116 TD
0 Tc
(p)Tj
/F7 1 Tf
.6566 0 TD
(<)Tj
/F5 1 Tf
.7084 0 TD
[(0.)18.5(00)20.8(01)15.1(,)-383.6(l)0(o)15(w)0(e)18.8(r)-387(da)19.7(y)-392.8(3)-387(FS)21.2(H)-387.9(7)0(.)18.5(3)0(1)]TJ
/F7 1 Tf
12.7347 0 TD
()Tj
/F5 1 Tf
.7084 0 TD
[(2.)18.5(9)-387(v)0(s)15.3(.)-389.3(8.)24.3(3)]TJ
/F7 1 Tf
4.5098 0 TD
()Tj
/F5 1 Tf
.7084 0 TD
[(3.)18.5(8)-156.6(n)0(g)20.8(/)0(m)19.5(L)0(,)]TJ
/F6 1 Tf
-20.0265 -1.1174 TD
(p)Tj
/F7 1 Tf
.6566 0 TD
(<)Tj
/F5 1 Tf
.7084 0 TD
[(0.)18.5(00)20.8(01)15.1(\),)-517.1(fe)14(we)18.8(r)-531(m)0(a)18.4(t)0(u)20.7(r)0(e)-521.7(f)0(o)20.9(l)0(l)14.8(i)0(c)19.6(l)0(e)19.6(s)-530.8(\(1)20.9(.6)]TJ
/F7 1 Tf
15.2459 0 TD
()Tj
/F5 1 Tf
.7084 0 TD
[(0.)18.5(9)-531(v)0(s)21(.)-533.3(1.)24.3(7)]TJ
/F7 1 Tf
4.7921 0 TD
()Tj
/F5 1 Tf
.7142 0 TD
[(0.)24.3(9,)]TJ
/F6 1 Tf
-22.8257 -1.1116 TD
(p)Tj
/F7 1 Tf
.6566 0 TD
(=)Tj
/F5 1 Tf
.7084 0 TD
[(0.)18.5(03)20.8(\),)-200.3(an)13.9(d)-208.4(t)0(h)20.7(i)0(c)19.6(k)0(e)19.7(r)-208.4(en)13.9(do)20.8(me)18.4(tr)20.7(iu)20.7(m)-209.7(a)0(t)-205.1(s)0(u)21(r)0(g)20.9(e)-209.6(\(8)20.9(.7)]TJ
/F7 1 Tf
17.5153 0 TD
()Tj
/F5 1 Tf
.7084 0 TD
[(1.)18.5(8)-208.4(v)0(s)21(.)-210.8(8.)18.5(4)]TJ
/F7 1 Tf
4.1527 0 TD
()Tj
/F5 1 Tf
-23.7415 -1.1116 TD
[(1.)18.5(6)-156.6(m)0(m)18.4(,)]TJ
/F6 1 Tf
3.4328 0 TD
(p)Tj
/F7 1 Tf
.6566 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
[(0.)24.3(00)20.8(03)15.1(\),)-240.6(co)19.7(mp)19.6(ar)14(ed)-239.5(wi)14.1(th)-244.2(he)19.7(te)19.6(ro)20.9(se)19.9(xu)20.8(al)-245.4(wo)14.2(m)15(e)0(n)13.9(.)-251.1(No)]TJ
-4.8036 -1.1174 TD
[(di)14.9(ff)20.9(er)19.7(en)19.7(ce)18.5(s)-271.6(i)0(n)-261.5(B)0(M)18.9(I)0(,)-263.7(B)0(A)18.9(F)0(C)20(,)-274.1(TM)18.7(SC)-262.3(on)-261.4(SA)20.1(,)-268.4(o)0(r)-261.4(p)0(a)19.7(r)0(i)15(t)0(y)-261.5(w)0(e)18.8(r)0(e)-262.5(o)0(b)20.8(-)]TJ
0 -1.1116 TD
[(se)14.1(rv)20.9(ed)-279.8(am)18.5(on)20.8(g)-289.1(s)0(t)15.1(u)0(d)20.8(y)-289.1(co)19.7(ho)20.8(rt)15(s.)]TJ
1.0137 -1.1116 TD
[(A)-307.2(comparison)-314(of)-307.4(patient)-309.9(demographics)-311.6(and)-309.7(cycle)-308.6(charac-)]TJ
-1.0137 -1.1174 TD
[(teristics)-404(among)-399.6(lesbian)-401.8(women)-400.4(undergoing)-403.9(natural)-396.2(and)-401.9(OI)]TJ
0 -1.1116 TD
[(cycles)-349.9(is)-347.7(presented)-347.4(in)-342.1(Table)-349(3.)-344.4(Lesbian)-351(women)-342.8(undergoing)]TJ
T*
[(OI)-325.6(cy)19.7(cl)19.5(es)-325.7(ha)19.7(d)-335.2(a)-336.3(hi)20.7(gh)20.8(er)-325.9(BM)18.9(I)-335.1(\()0(2)20.9(6)0(.)18.5(3)]TJ
/F7 1 Tf
13.9615 0 TD
()Tj
/F5 1 Tf
.7084 0 TD
[(5.)18.5(7)-329.4(v)0(s)15.3(.)-331.7(24)20.8(.6)]TJ
/F7 1 Tf
9.843 0 0 9.843 252.2834 78.7464 Tm
()Tj
/F5 1 Tf
.7084 0 TD
[(5.)18.5(7)-156.6(k)0(g)20.8(/)0(m)]TJ
7.3823 0 0 6.5614 292.8188 83.1118 Tm
(2)Tj
9.843 0 0 9.843 296.3905 78.7464 Tm
(,)Tj
/F6 1 Tf
-24.041 -1.1174 TD
(p)Tj
/F7 1 Tf
.6451 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0218 Tc
[(0.003\),)-295.9(l)0(ower)-299.3(day)-299.4(3)-299.4(FSH)-300.2(\(7)5.9(.31)]TJ
/F7 1 Tf
12.0954 0 TD
0 Tc
()Tj
/F5 1 Tf
.6912 0 TD
-.0212 Tc
[(2.9)-298.8(v).7(s.)-295.3(8.1)]TJ
/F7 1 Tf
4.1988 0 TD
0 Tc
()Tj
/F5 1 Tf
.6969 0 TD
-.0228 Tc
(4.8,)Tj
/F6 1 Tf
1.7106 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6451 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0277 Tc
[(0.)-8.1(0)-5.8(4)0(\))-5.7(,)]TJ
-22.077 -1.1116 TD
0 Tc
[(more)-513.6(mature)-511.4(follicles)-513.6(at)-510.3(the)-517.2(time)-513.9(of)-509(surge)-513.3(\(1.6)]TJ
/F7 1 Tf
20.6773 0 TD
()Tj
/F5 1 Tf
.72 0 TD
[(0.9)-512.5(vs.)]TJ
4.1124 44.9027 TD
(0.96)Tj
/F7 1 Tf
1.9122 0 TD
()Tj
/F5 1 Tf
.72 0 TD
[(0.3)-328.2(follicles,)]TJ
/F6 1 Tf
5.3968 0 TD
(p)Tj
/F7 1 Tf
.6624 0 TD
(<)Tj
/F5 1 Tf
.72 0 TD
[(0.0001\),)-266.9(and)-269.4(thinner)-262.5(endometrial)-264.9(lin-)]TJ
-9.4114 -1.1116 TD
[(ings)-246.3(at)-245.4(the)-246.5(time)-243.2(of)-249.8(surge)-242.6(\(8.7)]TJ
/F7 1 Tf
11.6288 0 TD
()Tj
/F5 1 Tf
.72 0 TD
[(1.8)-241.8(vs.)-247.3(9.1)]TJ
/F7 1 Tf
4.291 0 TD
()Tj
/F5 1 Tf
.7142 0 TD
[(1.7)-166.9(mm,)]TJ
/F6 1 Tf
3.4731 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
(0.01\))Tj
-22.2094 -1.1116 TD
[(compared)-238.1(with)-241.7(those)-237(undergoing)-236.9(natural)-240.7(cycles.)-238.1(Both)-241.7(groups)]TJ
0 -1.1174 TD
[(were)-289.8(similar)-286.7(in)-290.3(age,)-291.3(AMH,)-291.6(BAFC,)-287.1(gravidity,)-285.6(and)-292.4(parity)-284.5(and)]TJ
0 -1.1116 TD
[(had)-298.2(comparabl)8.3(e)-301.8(S)0(A)-302.4(parameter)7.2(s)-300.4(a)0(t)-297.2(the)-298.3(time)-300.8(of)-295.9(IUI.)]TJ
1.0137 -1.1116 TD
[(There)-250.9(were)-249.5(no)-249.9(signicant)-249.5(differences)-252.8(in)-250(CP,)-248.4(OP/LB,)-253.9(EPL,)]TJ
-1.0137 -1.1116 TD
-.0214 Tc
[(CPL)-6.4(,)-203.4(o)-5.2(r)-206.8(mu)-5.2(lti)-5.3(ple)-213.7(g).5(es)-5(tat)-5.4(i).4(on)-212.6(rat)-5.4(e)]TJ
11.8995 0 TD
-.0198 Tc
[(when)-205.2(compa)-4.8(r)2.2(ing)-205.2(l)2(e)-4.8(s)2.3(bian)-205.2(w)-4.5(o)2.1(men)]TJ
-11.8995 -1.1174 TD
0 Tc
[(an)13.9(d)-225.7(h)0(e)13.9(t)0(e)13.8(r)0(o)15.1(s)0(e)14.1(x)0(u)15.1(a)0(l)-222.4(w)0(o)14.2(m)0(e)18.4(n)-231.5(un)15.1(de)13.9(rg)15.1(oi)20.7(ng)-221.1(na)13.9(tu)15(ra)14(l)-231.6(\()0(T)13.9(a)0(b)19.7(l)0(e)-222.4(4)0(\))-226.8(a)0(n)19.7(d)-231.5(OI)]TJ
0 -1.1116 TD
[(cyc)11.7(le)13.8(s)-323.4(\(Ta)11.7(ble)-315.6(5\).)-316.6(Af)14.2(ter)-315.6(adj)12.7(ust)14(ing)-314.5(for)-314.3(all)-315.7(obs)14.2(erv)12.9(ed)-314.4(con)12.8(fou)14(nd-)]TJ
T*
[(ers)13(,)-435.4(the)-425.1(lik)13.7(eli)12.6(hoo)14(d)-433.1(o)0(f)-434.1(C)0(P)-429.3(\(na)12.8(tur)13.9(al)-435.5(cy)13.9(cle)11.5(:)-439(O)0(R)-430.3(0.4)-426.1([95)14(%)-434.1(C)0(I)]TJ
0 -1.1174 TD
[(0.)12.7(12)14(.2])11.7(,)-193.5(O)0(I)-193.1(cyc)11.7(le:)-189(OR)-194.2(1.4)-189.9([95)19.8(%)-198(C)0(I)-193.3(0.4)11.7(4.)17.4(6]\))14(,)-199.3(OP/)13.1(LB)-194.5(\(na)12.8(tur)13.9(al)]TJ
0 -1.1116 TD
[(cyc)11.7(le)13.8(:)-312.3(O)0(R)-303.6(0.5)-299.4([95)14(%)-313.2(C)0(I)-302.7(0.1)11.7(3)15.1(.6])11.7(,)-308.7(O)0(I)-308.3(c)0(y)13.9(cle)11.5(:)-312.3(O)0(R)-303.6(3.2)-299.4([95)14(%)-307.4(C)0(I)]TJ
T*
[(0.)12.7(42)14(9.1)11.6(]\),)-345.4(EPL)-351.1(\(na)12.8(tur)13.9(al)-354.8(cyc)11.7(le:)-350.3(OR)-355.4(1.7)-351.2([95)14(%)-359.3(C)0(I)-354.5(0.1)17.4(31)14(.4])11.7(,)]TJ
0 -1.1174 TD
[(OI)-538.7(cy)13.9(cle)11.5(:)-542.6(O)0(R)-539.8(0)0(.)12.8(7)-542.5([95)14(%)-537.8(C)0(I)-538.9(0.1)11.6(8)15.1(.1])11.7(\),)-534.4(and)-534.4(CPL)-529.5(\(na)12.8(tur)13.9(al)]TJ
0 -1.1116 TD
[(cyc)11.7(le)13.8(:)-381.4(O)0(R)-378.5(0)0(.)12.7(1)-381.2([95)14(%)-376.5(C)0(I)-377.6(0)0(.)12.7(002)14(4.)11.6(2],)-368.5(OI)-371.7(cyc)11.7(le:)-373.3(0.)12.7(6)-381.2([95)14(%)-376.5(C)0(I)]TJ
T*
[(0.)12.7(14)14(.1])11.7(\))-502.2(w)0(e)13(r)0(e)-498.7(not)-493(sig)14(ni)14(can)11.7(tly)-493.1(di)14.9(ffe)12.9(ren)12.9(t)-502.3(bet)12.7(wee)10.8(n)-502.2(l)0(e)13.8(sbi)14.1(an)]TJ
0 -1.1174 TD
[(wom)17.6(en)-291.3(and)-286.7(het)12.7(ero)12.8(sex)13(ual)-286.8(wom)11.9(en.)]TJ
1.0137 -1.1116 TD
[(When)-359.2(evaluating)-366.2(lesbian)-361.4(women)-365.9(who)-361.3(underwent)-358.8(natural)]TJ
-1.0137 -1.1116 TD
[(cycle/IUI)-360.1(compared)-364.8(with)-362.6(OI/IUI,)-357.4(no)-359.3(signicant)-364.7(differences)]TJ
T*
[(in)-250(CP,)-254.2(OP/LB,)-253.9(EPL,)-250.9(and)-257.9(CPL)-253(rates,)-253.1(despite)-252(a)-255.7(higher)-255.5(average)]TJ
0 -1.1174 TD
[(number)-412.2(of)-416.9(mature)-413.4(follicles)-421.5(at)-412.4(the)-413.5(time)-416(of)-416.9(surge)-415.4(in)-411.3(the)-413.5(OI)]TJ
0 -1.1116 TD
[(group,)-394.8(were)-393.5(observed.)-400.2(However,)-395.3(for)-394.9(lesbian)-396(women,)-398.1(there)]TJ
T*
[(was)-563.8(a)-560.9(statistically)-565.5(higher)-560.8(multiple)-564.7(gestation)-565.4(rate)-559.8(among)]TJ
0 -1.1174 TD
[(those)-300.4(undergoing)-294.5(OI)-302.5(compared)-301.5(with)-299.3(those)-294.6(undergoing)-300.3(natu-)]TJ
0 -1.1116 TD
[(ral)-263.8(cycles)-263.5(\(11.8%)-263.4(vs.)-258.9(0%,)]TJ
/F6 1 Tf
10.5172 0 TD
(p)Tj
/F7 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(0.01\))-261.2(\(Table)-263.7(6\).)-264.8(Similarly,)-263.7(het-)]TJ
-11.8995 -1.1116 TD
[(erosexual)-675.7(women)-671.1(undergoing)-674.6(OI)-671.2(compared)-675.9(with)-673.7(those)]TJ
0 -1.1174 TD
[(undergoing)-427(natural)-430.7(cycles)-430.5(had)-424.9(a)-428.5(higher)-428.3(multiple)-432.2(gestation)]TJ
0 -1.1116 TD
[(rate)-300.6(\(12.4%)-303.7(vs.)-299.2(1.2%,)]TJ
/F6 1 Tf
9.0946 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
(0.0003\).)Tj
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 171.8362 Tm
(Discussion)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 155.3952 Tm
.012 Tc
[(Lesbi)5(an)-357.7(women)-363.5(p)-.6(r)5.2(e)-1.8(s)5.3(e)-1.8(nt)-357.8(fo)5.1(r)-363.4(r)-.6(epr)5.2(odu)5.1(ct)5(iv)5.1(e)-364.6(c)-1.8(are)-358.9(o)-.6(f)5.2(t)-.7(en)-357.7(no)5.1(t)]TJ
-1.0137 -1.1116 TD
.0116 Tc
[(f)4.8(o)-1(r)-225.6(a)-226.8(medi)4.6(cal)-225.8(i)-1.1(nd)4.7(icat)4.6(io)4.7(n,)-228(b)4.7(u)-1(t)-225.8(i)-1.1(n)4.7(s)-.8(t)4.6(e)-2.2(ad)-225.6(to)-225.6(gain)-225.6(access)-225.4(t)4.6(o)-231.4(r)4.8(e)-2.2(p)4.7(r)-1(o)4.7(-)]TJ
0 -1.1174 TD
.0121 Tc
[(d)5.2(u)-.5(ctiv)5.2(e)-456.7(o)-.5(p)5.2(por)5.3(tu)5.2(ni)5.1(ties)-461.1(t)5.1(hat)-455.7(a)-1.7(re)-456.7(n)5.2(o)-.5(t)-455.7(o)-.5(t)5.1(h)-.5(erwi)5.1(se)-456.7(av)5.2(ai)5.1(lable)-456.7(t)5.1(o)]TJ
0 -1.1116 TD
.0075 Tc
[(th)-5.1(em)-6.3(.)-301.2(A)-6(lt)-5.2(ho)-5.1(ug)-5.1(h)-304.6(l).5(e)-6.3(s).8(b)-5.1(i)-5.2(an)-304.6(wo)-5.1(me)]TJ
12.4755 0 TD
.3064 Tc
[(nh)293.8(a)298.4(v)293.8(e)-6.9(a)298.4(c)292.6(c)298.4(e)292.6(s)299.7(s)-5.5(t)293.7(om)292.6(a)298.4(n)293.8(yt)293.7(r)293.8(e)298.4(a)292.6(t)299.4(-)]TJ
-12.4755 -1.1116 TD
.0073 Tc
[(me)-6.5(nt)-385.6(o)-5.3(p).4(t)-5.4(i).3(o)-5.3(n).4(s)-5.1(,)-387.8(in)-5.3(cl)-5.4(ud)-5.3(in)-5.3(g)-385.5(t).3(h)-5.3(e)-386.6(ch)-5.3(oi)-5.4(c)-6.5(e)-380.9(o)-5.3(f)-385.4(sh)-5.3(a)-6.5(r).5(e)-6.5(d)-379.7(m)-6.5(o).4(t)-5.4(h)-5.3(er)-5.3(ho)-5.3(od)]TJ
T*
.0118 Tc
[(t)4.8(hro)4.9(ug)4.9(h)-294.6(c)3.8(o-)5(IVF)5.1(,)-291.1(th)4.9(ese)-290(t)-.9(r)5(e)-2(atmen)4.9(t)-.9(s)-294.4(c)3.8(ome)-295.7(w)4.1(it)4.8(h)-294.6(a)-290(hig)4.9(h)-294.6(b)4.9(u)-.8(r)5(d)-.8(en)]TJ
0 -1.1174 TD
.0132 Tc
[(o)6.3(f)-201(co)6.3(st)-195.4(and)-195.2(i).5(n)6.3(v).6(a)5.2(s).8(iv)6.3(en)6.3(es)6.5(s)-200.8(t).5(h)6.3(a)-.6(t)-195.4(t).5(he)5.2(ir)-195.2(he)5.2(ter)6.4(o).6(s)6.5(e)-.6(x)6.3(u).6(al)-195.4(co)6.3(un)6.3(ter)6.4(p).6(a)5.2(r).6(t)6.2(s)]TJ
0 -1.1116 TD
.0115 Tc
[(d)4.6(o)-335.2(no)4.6(t)-335.3(a)-2.3(l)4.5(w)-2(ays)-335(e)3.5(xp)4.6(er)4.7(ien)4.6(c)-2.3(e.)-337.5(I)4.7(n)-335.2(addi)4.5(ti)4.5(on)4.6(,)-337.5(s)4.8(everal)-335.3(ot)4.5(her)-335.1(q)-1.1(u)4.6(e)-2.3(s)4.8(-)]TJ
T*
.0119 Tc
[(t)4.9(i)-.8(o)5(n)-.7(s)-501.6(r)-.7(egard)5(i)-.8(ng)-501.8(who)-501.8(w)4.2(il)4.9(l)-501.9(c)-1.9(arry)-496(the)-497.2(g)-.7(es)5.2(tati)4.9(on,)-498.4(th)5(e)-503(d)-.7(o)5(n)-.7(o)5(r)]TJ
0 -1.1174 TD
.0068 Tc
[(sp)-5.8(e)-7(r)0(m)-375.7(s).1(o)-5.8(u)-5.8(r)0(c)-7(e)-1.2(,)-371(a)-7(n)-5.8(d)-368.7(t)-5.9(h)-.1(e)-375.6(c)-7(os)-5.6(t)-374.6(o)-.1(f)-374.4(u)-5.8(si)-5.9(ng)-374.4(a)-7(n)-368.7(a)-7(n)-5.8(on)-5.8(ym)-7(ou)-5.8(s)-374.2(r)0(a)-7(t)-.2(h)-5.8(e)-1.2(r)]TJ
ET
59.754 708.888 239.131 .28345 re
f
59.754 432.34 239.131 .22681 re
f
59.754 650.381 239.131 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 74.8913 725.5557 Tm
0 Tc
(Table)Tj
/F5 1 Tf
2.9657 0 TD
(3.)Tj
/F9 1 Tf
1.2496 0 TD
[(Lesbian)-302.8(Women)-302.8(Undergoing)-300.5(Natural)]TJ
-1.192 -1.0135 TD
[(and)-303.2(Ovulation)-299.6(Induction)-300.2(Cycles)]TJ
/F6 1 Tf
6.1444 -2.9541 TD
(Natural)Tj
.3282 -1.0135 TD
(cycles)Tj
-.5471 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(451\))Tj
3.507 3.0405 TD
(Ovulation)Tj
.1094 -1.0135 TD
(induction)Tj
.668 -1.0135 TD
(cycles)Tj
-.5471 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(441\))Tj
/F5 1 Tf
4.722 -1.0077 TD
(p)Tj
/F6 1 Tf
-12.3175 0 TD
(Mean)Tj
/F7 1 Tf
2.4474 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
[(SD)-1073.9(Mean)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F6 1 Tf
.7198 0 TD
(SD)Tj
/F5 1 Tf
-18.698 -1.9003 TD
[(Age)-304.4(\(years\))-5324.2(36.1)]TJ
/F7 1 Tf
11.9893 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(3.8)-1571.7(36.2)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(4.0)-2124.5(0.79)]TJ
-18.1624 -1.0135 TD
[(Body)-304.4(mass)]TJ
.9962 -1.0077 TD
[(index)-300(\(kg/m)]TJ
7.3837 0 0 6.5625 118.0346 622.3746 Tm
(2)Tj
9.845 0 0 9.845 121.7197 618.0093 Tm
(\))Tj
3.7776 1.0077 TD
(24.6)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(5.7)-1571.7(26.3)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(5.7)-2124.5(0.003)]TJ
-18.1624 -2.0212 TD
[(Day)-304.4(3)-300.4(follicle-)]TJ
.9962 -1.0135 TD
(stimulating)Tj
0 -1.0077 TD
[(hormone)-297.2(\(ng/mL\))]TJ
9.5765 2.0213 TD
(8.1)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(4.8)-1571.7(7.31)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(2.9)-2124.5(0.04)]TJ
-18.1624 -3.0348 TD
(Anti-Mu)Tj
3.0866 .0115 TD
()Tj
.4146 -.0115 TD
(llerian)Tj
-2.505 -1.0135 TD
[(hormone)-297.2(\(ng/dL\))]TJ
9.5765 1.0135 TD
(4.0)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(2.8)-2072.7(4.1)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(4.1)-2124.5(0.84)]TJ
-18.1624 -2.027 TD
[(Basal)-307.7(antral)-302.3(follicle)]TJ
.9962 -1.0077 TD
(count)Tj
9.8241 1.0077 TD
(19)Tj
/F7 1 Tf
1.169 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(3.6)-1571.7(15.5)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(7.3)-2124.5(0.86)]TJ
-18.1624 -2.0212 TD
[(Number)-302.8(of)-301.4(mature)]TJ
.9962 -1.0135 TD
[(follicles)-299.7(at)-302.8(the)]TJ
T*
[(time)-300.3(of)-301.4(surge)]TJ
9.0755 2.027 TD
(0.96)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.3)-2072.7(1.6)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
(0.9)Tj
/F7 1 Tf
2.8217 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.0001)Tj
-21.537 -3.0348 TD
[(Endometrial)-304(thickness)]TJ
.9962 -1.0135 TD
[(at)-297(the)-303.8(time)-300.3(of)]TJ
T*
[(surge)-299.6(\(mm\))]TJ
9.5765 2.027 TD
(9.1)Tj
/F7 1 Tf
1.4166 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(1.7)-2072.7(8.7)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(1.8)-2124.5(0.01)]TJ
-18.1624 -3.0405 TD
[(Gravidity)-6230.7(0.41)]TJ
/F7 1 Tf
11.9893 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.8)-1571.7(0.50)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(0.7)-2124.5(0.34)]TJ
-18.1624 -1.0077 TD
[(Parity)-7677.7(0.11)]TJ
/F7 1 Tf
11.9893 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(0.5)-1571.7(0.16)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(0.6)-2124.5(0.27)]TJ
-18.1624 -1.0135 TD
[(Total)-301.3(motile)-302.5(sperm)]TJ
.9962 -1.0135 TD
[(count)-300(\(millions)]TJ
0 -1.0077 TD
[(of)-295.7(sperm\))]TJ
9.0755 2.0213 TD
(46.8)Tj
/F7 1 Tf
1.9176 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(12.2)-1071.7(47.3)]TJ
/F7 1 Tf
4.7393 0 TD
()Tj
/F5 1 Tf
.7141 0 TD
[(13.1)-1624.5(0.54)]TJ
ET
310.847 698.967 239.074 .22675 re
f
310.847 522.028 239.074 .22681 re
f
310.847 650.381 239.074 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 326.7779 725.5557 Tm
(Table)Tj
/F5 1 Tf
2.9714 0 TD
(4.)Tj
/F9 1 Tf
1.2496 0 TD
[(Pregnancy)-298.5(Outcomes)-304.2(Among)-301.3(Lesbian)]TJ
-2.551 -1.0135 TD
[(and)-297.5(Heterosexual)-301.1(Women)-302.8(Undergoing)]TJ
5.1827 -1.0135 TD
[(Natural)-302.2(Cycles)]TJ
/F6 1 Tf
1.2208 -1.9406 TD
(Lesbian)Tj
.167 -1.0135 TD
(women)Tj
-.357 -1.0135 TD
(\()Tj
/F5 1 Tf
.3282 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(451\))Tj
4.6068 2.027 TD
(Heterosexual)Tj
1.2554 -1.0135 TD
(women)Tj
-.6104 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(1177\))Tj
/F5 1 Tf
4.9696 -1.0077 TD
(p)Tj
/F6 1 Tf
-13.0373 0 TD
.3014 Tc
(%\()Tj
/F5 1 Tf
1.4684 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
4.9015 Tc
[(\)%)4565.5(\()]TJ
/F5 1 Tf
6.7375 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
(\))Tj
/F5 1 Tf
-19.3314 -1.9003 TD
(Clinical)Tj
.9905 -1.0135 TD
[(pregnancy)-300.3(rate)]TJ
7.6013 1.0135 TD
[(9.5%)-335.6(\(43/451\))-1108(7.2%)-329.8(\(85/1177\))-608(0.12)]TJ
-8.5917 -2.0213 TD
(Ongoing)Tj
.9905 -1.0135 TD
(pregnancy/live)Tj
T*
[(birth)-299(rate)]TJ
7.6013 2.027 TD
[(7.3%)-335.6(\(33/451\))-1108(5.7%)-329.8(\(67/1177\))-608(0.22)]TJ
-8.5917 -3.0347 TD
[(Early)-301.2(pregnancy)]TJ
.9905 -1.0135 TD
[(loss)-303.2(rate)]TJ
7.6013 1.0135 TD
[(3.8%)-335.6(\(17/451\))-1108(2.7%)-329.8(\(32/1177\))-608(0.27)]TJ
-8.5917 -2.027 TD
(Clinical)Tj
.9905 -1.0135 TD
(pregnancy)Tj
0 -1.0077 TD
[(loss)-303.2(rate)]TJ
7.1003 2.0213 TD
[(23.3%)-336.6(\(10/43\))-1107(21.2%)-330.8(\(18/85\))-1608(0.79)]TJ
-8.0908 -3.0348 TD
[(Multiple)-298.5(gestation)]TJ
.9905 -1.0135 TD
(rate)Tj
8.3499 1.0135 TD
[(0%)-337(\(0/43\))-2108(1.2%)-329.8(\(1/85\))-2108(0.52)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.5368 Tm
[(UNDERSTANDING)-308.8(THE)-303.5(LESBIAN)-304.3(REPRODUCTIVE)-302.5(EXPERIENCE)-22856.8(65)]TJ
ET
endstream
endobj
43 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 495.2692 Tm
0 0 0 rg
.007 Tc
0 Tw
[(t)-5.7(h).1(a)-6.8(n)-397.3(kn)-5.6(ow)-6.5(n)-397.3(s).3(p)-5.6(e)-6.8(rm)-398.5(do)-5.6(n)-5.6(o).1(r)-397.2(m)-6.8(us)-5.4(t)-397.4(b).1(e)-398.4(a)-6.8(dd)-5.6(re)-6.8(s)-5.4(s).3(e)-6.8(d)-397.3(wi)-5.7(th)-397.3(l)-5.7(e)-1(s)-5.4(b)-5.6(ia)-6.8(n)]TJ
0 -1.1116 TD
.0114 Tc
[(wo)4.5(men.)-222.4(Thu)4.5(s)-1(,)-222.4(t)-1.3(he)-221.2(us)4.7(ual)-226(t)-1.3(r)4.6(e)-2.4(atmen)4.5(t)-226(paradi)4.4(gms)-225.6(u)-1.2(s)4.7(e)-2.4(d)-225.8(f)4.6(or)-220.1(a)-227(h)-1.2(et-)]TJ
T*
.012 Tc
[(er)5.2(os)5.3(exu)5.1(a)-1.8(l)-202.3(c)4(ou)5.1(pl)5(e)-203.4(e)-1.8(x)5.1(p)-.6(eriencin)5.1(g)-202.2(i)-.7(nf)5.2(er)5.2(ti)5(lit)5(y)-202.2(m)-1.8(ay)-202.2(need)-202.2(t)5(o)-202.2(be)-203.4(ad-)]TJ
0 -1.1174 TD
.0132 Tc
[(ju)6.3(st)6.2(ed)-298.9(f)6.4(o).6(r)-293.1(l).5(es)6.5(bi)6.2(an)-298.9(p)6.3(a)-.6(t)6.2(i).5(e)5.2(n).6(t)6.2(s).8(.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Even)-438.7(though)-444.5(lesbian)-442.1(women)-440.8(have)-438.7(been)-444.5(using)-437.4(ART)-444.1(for)]TJ
-1.0137 -1.1116 TD
[(years,)-235.7(there)-232.6(is)-226.8(limited)-235.2(information)-233.7(regarding)-231.2(their)-237.3(experience)]TJ
0 -1.1174 TD
[(and)-304(likelihood)-312.2(of)-301.7(success)-310.1(with)-310.8(treatments.)-307.3(This)-305(lack)-312.1(of)-301.7(data)]TJ
0 -1.1116 TD
[(may)-357(be)-354.7(a)-353.6(result)-353.4(of)-359.3(incomplete)-355.9(societal)-358.1(and)-355.8(political)-358.5(accep-)]TJ
T*
[(tance)-233.8(of)-232.6(sexual)-233.5(minority)-235(individuals;)-233.7(however,)-238.9(with)-230.2(legaliza-)]TJ
T*
[(tion)-442.4(of)-439.9(same-sex)-445.1(marriage)-445.6(by)-439.9(the)-442.3(U.S.)-441.8(Supreme)-443.1(Court)-444.4(in)]TJ
0 -1.1174 TD
[(2015)-286.6(and)-292.4(support)-284.1(from)-293.5(the)-286.8(American)-291(Society)-292.4(for)-285.5(Reproduc-)]TJ
0 -1.1116 TD
[(tive)-495.4(Medicine,)]TJ
7.3823 0 0 6.5614 121.5496 379.1054 Tm
(8)Tj
9.843 0 0 9.843 130.1102 374.7401 Tm
[(these)-503.1(barriers)-494.8(are)-500.9(breaking)-495.1(down.)-498.3(In)-497.5(the)]TJ
-6.9174 -1.1116 TD
[(United)-337.2(States)-337.1(alone,)-339.7(between)-340.5(6)-335.2(and)-338.5(14)-330.5(million)-337.8(children)-339.7(are)]TJ
0 -1.1174 TD
[(being)-248.7(raised)-250.7(by)-244.1(at)-251.2(least)-249.8(one)-246.4(gay)-246.4(or)-249.8(lesbian)-246.2(parent.)]TJ
7.3823 0 0 6.5614 256.422 357.1653 Tm
(8)Tj
9.843 0 0 9.843 262.6015 352.7999 Tm
(However,)Tj
-20.3778 -1.1116 TD
[(as)-245.1(of)-249.8(2014,)-244(only)-246.4(60.2%)-245(of)-244.1(Society)-246.3(for)-245.1(Assisted)-252.4(Reproductive)]TJ
T*
[(Technology)-210.5(clinics)-206.1(reported)-207(treating)-207.3(lesbian)-211.7(couples.)]TJ
7.3823 0 0 6.5614 268.8944 335.2818 Tm
(9,10)Tj
9.843 0 0 9.843 283.8614 330.9164 Tm
[(As)-204.5(a)]TJ
-22.5377 -1.1174 TD
[(result,)-316.5(there)-318.9(is)-318.9(a)-313.3(paucity)-321.3(of)-313.2(data)-317.9(regarding)-323.3(utilization)-314.7(trends)]TJ
0 -1.1116 TD
[(and)-355.8(the)-361.7(reproductive)-362.5(experience)-362.5(of)-353.5(lesbian)-361.4(women)-360.1(seeking)]TJ
T*
[(fertility)-305.4(treatment.)]TJ
1.0137 -1.1174 TD
[(In)-342(this)-344.3(large)-347.8(study,)-342.9(we)-344.1(found)-345.3(that)-345.6(approximately)-347.7(30%)-344.2(of)]TJ
-1.0137 -1.1116 TD
[(lesbian)-407.5(women)-406.2(undergoing)-403.9(care)-405.3(at)-406.7(a)-399.7(reproductive)-408.6(practice)]TJ
T*
[(underwent)-318.5(an)-308.6(HSG)-315.9(as)-314.2(part)-310.9(of)-313.2(their)-317.9(initial)-314.8(evaluation,)-312.1(which)]TJ
T*
[(was)-437.1(warranted)-440.6(as)-440.9(most)-437.5(of)-434.1(these)-439.7(women)-440.8(had)-436.4(a)-434.2(risk)-442(factor)]TJ
0 -1.1174 TD
[(for)-227.9(tubal)-231.6(disease.)-227.5(This)-230.2(rate)-225.7(of)-232.6(HSG)-223.8(testing)-233.7(is)-226.8(lower)-226.5(compared)]TJ
0 -1.1116 TD
[(with)-374.2(the)-373.2(heterosexual)-380.8(population)-375.4(with)-374.2(infertility)-376.9(issues)-375.9(un-)]TJ
T*
[(dergoing)-315.3(treatment;)-321.5(however,)-319.6(this)-315.5(difference)-321(may)-316.7(be)-314.4(due)-315.5(to)]TJ
0 -1.1174 TD
[(the)-430.8(fact)-427.3(that)-432(lesbian)-430.6(women)-429.2(are)-431.8(presumptively)-432.7(fertile)-430.8(and)]TJ
0 -1.1116 TD
[(therefore,)-224.2(many)-219.9(may)-218.8(lack)-220(an)-216.5(indication)-221.2(for)-216.3(the)-217.7(test.)-222.2(Still,)-216.6(pro-)]TJ
T*
[(viders)-520.3(must)-518.2(employ)-516(clinical)-519.7(judgment)-524.1(when)-519.1(determining)]TJ
0 -1.1174 TD
[(whether)-235.6(a)-232.6(patient)-235.1(is)-226.8(an)-233.7(appropriate)-234.7(candidate)-239.5(for)-227.9(an)-233.7(HSG,)-233(es-)]TJ
0 -1.1116 TD
[(pecially)-266.1(given)-266(that)-270.8(lesbian)-263.5(women)-268(tend)-264.9(to)-267.3(have)-265.9(a)-261.4(higher)-267.1(rate)]TJ
T*
[(of)-526.3(gynecologic)-534.2(problems)-529.5(\(i.e.)-529.8(chlamydia)-527.5(and)-528.6(salpingitis\))]TJ
T*
[(compared)-307.2(with)-299.3(heterosexual)-305.9(women.)]TJ
7.3823 0 0 6.5614 208.7999 148.9889 Tm
(3,11)Tj
9.843 0 0 9.843 72 133.6252 Tm
[(Although)-297.9(lesbian)-303.8(women)-296.8(may)-299.4(not)-297.2(always)-303.5(have)-300.5(a)-296(medical)]TJ
-1.0137 -1.1116 TD
[(diagnosis)-247.1(of)-249.8(infertility,)-247.8(our)-245.2(ndings)-249.4(demonstrate)-253(comparable)]TJ
T*
[(pregnancy)-393.5(rates)-387.9(between)-392.3(lesbian)-384.5(and)-390.4(infertile)-392.8(heterosexual)]TJ
0 -1.1174 TD
[(women)-285.2(undergoing)-277.2(both)-281(OI)-279.5(with)-282(oral)-282.1(medications)-287.7(and)-275.2(natu-)]TJ
0 -1.1116 TD
[(ral)-217.7(cycle)-216.5(IUI.)-214.9(This)-212.9(nding)-213.9(is)-215.2(in)-215.4(contrast)-218.5(to)-215.4(prior)-212.9(literature)-216.5(that)]TJ
T*
[(has)-424.7(suggested)-426.7(an)-423.8(improved)-420.2(pregnancy)-428.1(rate)-427.3(among)-422.6(lesbian)]TJ
0 -1.1174 TD
[(women)-308.3(compared)-307.2(with)-305(the)-309.9(general)-305(population)]TJ
7.3823 0 0 6.5614 245.9905 72.2834 Tm
(6,12)Tj
9.843 0 0 9.843 258.9731 67.8614 Tm
[(;)-300.7(however,)]TJ
-20.0092 -1.1116 TD
[(those)-294.6(studies)-302.5(have)-294.7(been)-294.7(limited)-298.6(by)-295.9(the)-298.3(inclusion)-293.5(of)-295.9(multiple)]TJ
25.504 44.367 TD
[(types)-283.1(of)-278.6(ART)-282.9(treatments)-280.8(and)-280.9(a)-278.7(lack)-283.3(of)-278.6(adjustment)-285.5(for)-279.7(possi-)]TJ
0 -1.1174 TD
[(ble)-384.7(confounders)-388.6(in)-382.5(the)-384.7(analysis.)-383.1(Although)-384.3(our)-383.4(ndings)-381.9(are)]TJ
0 -1.1116 TD
[(consistent)-243.7(with)-235.9(several)-241.5(other)-237.2(studies)-239.1(that)-242(identied)-237.1(no)-238.3(signif-)]TJ
T*
[(icant)-267.3(difference)-263.4(in)-261.5(pregnancy)-261(outcomes)-265.7(between)-265.6(lesbian)-263.5(and)]TJ
T*
[(heterosexua)-10.9(l)-369.8(women,)]TJ
7.3823 0 0 6.5614 398.2109 454.1668 Tm
(3,4,13)Tj
9.843 0 0 9.843 420.3778 449.8015 Tm
[(this)-373.1(is)-376.5(the)-373.2(rst)-378.5(to)-370.9(evaluate)-382.3(preg-)]TJ
-10.9031 -1.1174 TD
[(nancy)-353.4(rates)-353.3(in)-347.9(women)-354.4(only)-350.1(taking)-347.9(oral)-351.2(OI)-348.6(medications,)-354.5(in-)]TJ
0 -1.1116 TD
[(cluding)-302.9(both)-304(CC)-298(and)-304(letrozole.)]TJ
1.0137 -1.1116 TD
[(Th)25.4(is)-376.5(st)20.9(u)16.2(d)0(y)-376.6(i)0(s)-376.5(a)0(l)19.6(s)16.4(o)-392.8(t)16.1(he)-377.7(r)21(s)16.4(t)-392.9(t)16(o)-392.7(a)15(s)0(s)21.2(e)15(ss)-376.2(pr)20.9(e)15(g)0(n)26.6(a)0(n)25.4(c)0(y)-377.7(o)0(u)26.6(t)0(c)25.3(o)0(m)25.4(e)0(s)]TJ
-1.0137 -1.1174 TD
[(am)24.2(on)26.6(g)-173.9(l)16.1(es)19.9(b)16.2(i)0(a)25.3(n)-173.9(w)15.3(o)0(m)25.4(e)0(n)-158.9(p)0(u)26.6(r)0(s)26.8(u)0(i)20.7(n)16.2(g)-173.9(d)16.2(if)26.5(fe)25.5(re)25.5(nt)-157.8(ty)20.7(p)16.2(e)0(s)-158.7(o)0(f)-157.7(c)0(y)25.4(c)0(l)25.3(e)0(s)-158.7(b)0(e)19.7(f)16.2(or)26.6(e)]TJ
0 -1.1116 TD
[(IU)20(I)16.2(.)-302.9(A)-295.7(l)0(a)25.3(r)0(g)20.9(e)-296(pr)20.9(o)16.2(p)0(o)26.6(r)0(t)26.5(i)0(o)26.5(n)-300.6(of)-290.1(l)16(e)0(s)25.6(b)0(i)26.5(a)0(n)-291.3(w)15.3(om)25.4(en)-291.3(i)16(n)-300.6(t)16.1(h)0(e)-291.3(s)16.4(tu)20.7(d)16.2(y)-300.6(b)16.2(e)0(g)25.4(a)0(n)]TJ
T*
[(th)20.7(e)15(i)0(r)-221.2(r)0(e)25.5(p)0(r)26.6(o)0(d)26.6(u)0(c)25.4(t)0(i)20.6(v)16.2(e)-238.4(j)16.1(ou)26.6(rn)26.6(ey)-222.2(wi)25.6(th)-221.2(a)-238.4(n)16.2(at)25.3(ur)20.9(a)15(l)0(/)26.3(I)0(U)25.8(I)-237.2(c)15(y)0(c)25.4(l)0(e)-222.4(b)0(e)25.4(f)0(o)26.6(r)0(e)-222.2(p)0(r)20.9(o)16.2(-)]TJ
0 -1.1174 TD
[(ce)24.3(ed)19.7(i)16.1(n)0(g)-163.5(t)0(o)-163.6(o)0(v)26.6(a)0(r)25.5(i)0(a)19.6(n)-173.9(st)26.7(im)25.2(ul)26.5(at)25.3(io)26.5(n)-179.6(w)0(i)25.6(t)0(h)-163.6(o)0(r)26.6(a)0(l)-164.8(m)0(e)24.2(d)0(i)26.5(c)0(a)24.3(t)0(i)20.6(o)16.2(ns)26.8(.)-176.2(A)0(l)25.6(t)0(h)20.7(o)16.2(ug)26.6(h)]TJ
0 -1.1116 TD
[(th)20.7(e)15(r)0(e)-291.3(w)15.3(as)-291.2(n)16.2(o)-300.6(di)26.5(ff)26.7(er)19.7(e)15(n)0(c)25.4(e)-301.8(in)-284.5(CP)-291.1(or)-290.2(O)15.3(P)0(/)26.6(L)0(B)-292.4(r)16.2(at)25.3(es)-291.2(a)15(m)0(o)25.4(n)0(g)-290.2(l)16(es)25.6(bi)26.5(an)]TJ
T*
[(wo)20(m)15(e)15(n)-220(w)15.3(h)0(o)-203.8(u)0(n)26.6(d)0(e)25.4(r)0(w)20(e)15(nt)-203.9(a)-215.4(n)0(a)25.4(t)0(u)20.7(r)16.2(al)-205.1(or)-203.8(OI)-204.6(cy)25.4(cl)25.3(e)-221.1(w)15.3(it)26.3(h)-220(I)16.2(UI)25.8(,)-216.5(a)-221.1(s)16.4(t)0(a)25.3(t)0(i)20.6(s)16.4(-)]TJ
0 -1.1174 TD
[(ti)20.6(c)15(a)0(l)25.3(l)0(y)-163.6(a)0(n)25.4(d)-173.9(cl)25.3(in)20.7(i)16(c)0(a)24.3(l)0(l)26.3(y)-179.6(s)16.4(i)0(g)26.5(n)0(i)26.5()0(c)25.6(a)0(n)25.4(t)0(l)20.6(y)-173.9(h)16.2(i)0(g)20.7(h)16.2(er)-164.6(m)15(u)0(l)26.5(t)0(i)20.6(p)16.2(le)-164.8(g)16.2(e)0(s)19.9(t)16(at)25.3(io)26.5(n)-179.6(r)16.2(at)25.3(e)]TJ
0 -1.1116 TD
[(wa)24.6(s)-254.3(o)0(b)26.6(s)0(e)19.9(r)16.2(ve)25.4(d)-254.5(a)15(mo)25.4(ng)-244.1(l)16.1(e)0(s)25.6(b)0(i)20.7(a)15(n)-254.5(w)15.3(om)25.4(en)-239.5(wh)20(o)-248.8(u)0(n)26.6(d)0(e)25.4(r)0(w)20(e)15(nt)-238.5(OI)-244.9(c)15(o)0(m)25.4(-)]TJ
T*
[(pa)19.7(r)16.2(e)0(d)-176.1(w)15.3(it)20.6(h)-185.4(t)16.1(ho)20.8(s)16.4(e)-186.6(wh)20(o)-185.4(u)16.2(nd)26.6(er)19.7(w)15.3(e)0(n)25.4(t)-185.5(a)-192.3(n)16.2(at)25.3(ur)26.6(al)-176.3(cy)25.4(cl)25.3(e/)25.3(IU)20(I)-185.4(\()16.2(11)20.8(.)13.9(8)16.2(%)-186.5(v)0(s)21(.)]TJ
T*
[(0%)25.5(,)]TJ
/F6 1 Tf
1.8373 0 TD
(p)Tj
/F7 1 Tf
.6566 0 TD
(=)Tj
/F5 1 Tf
.7027 0 TD
[(0.)24.3(0)16.2(1)0(\))20.9(.)-297.2(A)15.3(s)-300.4(si)26.7(ng)20.8(l)16.1(e)0(t)25.3(o)0(n)-284.4(d)0(e)25.4(l)0(i)20.6(v)16.2(er)25.5(ie)25.3(s)-300.4(h)0(a)25.4(v)0(e)-285.6(b)0(e)25.4(c)0(o)25.4(m)0(e)-286.8(a)-301.8(pr)26.6(io)26.5(ri)20.7(t)16.1(y)]TJ
-3.1966 -1.1174 TD
[(in)-376.7(th)26.5(e)-388.2()0(e)25.6(l)0(d)-376.7(o)0(f)-376.5(r)16.2(ep)25.4(ro)20.9(d)16.2(u)0(c)25.4(t)0(i)26.3(v)0(e)-377.7(m)15(ed)25.4(ic)25.3(in)26.5(e,)-380.1(p)16.2(a)0(r)25.5(t)0(i)26.3(c)0(u)25.4(l)0(a)25.3(r)0(l)20.7(y)-387(f)16.2(o)0(l)26.5(l)0(o)26.5(w)0(i)25.6(n)0(g)]TJ
0 -1.1116 TD
[(AR)24.7(T)-353.6(t)16.1(re)25.5(at)25.3(me)24.2(nt)26.5(,)-349(t)0(h)26.5(i)0(s)-336.2(s)0(t)26.7(u)0(d)20.8(y)-346.7(su)26.8(gg)26.6(es)25.6(ts)-336.2(th)26.5(at)-337.6(pr)26.6(ol)26.5(on)26.6(ge)19.7(d)-346.7(t)16.1(re)25.5(at)19.6(m)14.9(e)15(nt)]TJ
T*
[(wi)19.8(t)16(h)-335.2(na)25.4(tu)26.5(ra)25.5(l)-335.3(I)0(U)25.8(I)-335.1(cy)25.4(cl)25.3(es)-325.7(m)15(a)0(y)-320.1(b)0(e)-325.9(o)16.2(ne)-325.9(m)15(e)0(t)25.3(h)0(o)26.6(d)-335.2(to)-324.9(m)14.9(i)0(n)26.5(i)0(m)25.2(i)0(z)25.3(e)-336.3(t)16.1(h)0(e)]TJ
0 -1.1174 TD
[(ri)20.7(s)16.4(k)-289.1(a)15(s)0(s)21.2(o)16.2(ci)25.3(at)25.3(ed)-274.1(wi)19.8(t)16(h)-289.1(m)15(u)0(l)26.5(t)0(i)26.3(p)0(l)26.5(e)-290.2(g)16.2(e)0(s)19.9(t)16.1(at)25.3(io)26.5(ns)26.8(.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 313.0582 237.5999 Tm
(Limitations)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 221.159 Tm
[(Some)-294.6(ndings)-295.5(in)-290.3(this)-292.5(study)-293.4(warrant)-299(further)-296.9(discussion.)-291.8(In)]TJ
-1.0137 -1.1116 TD
[(particular,)-502.1(the)-488.4(observed)-494.7(CP)-492.6(and)-494(OP/LB)-492.4(rates)-497.3(for)-492.8(lesbian)]TJ
0 -1.1174 TD
[(women)-550.2(are)-547(lower)-543.3(than)-547.1(expected)-549.2(in)-543.7(a)-543.7(fertile)-546(population.)]TJ
0 -1.1116 TD
[(These)-319.9(ndings)-318.5(may)-311(be)-320.1(explained)-318.9(by)-313.2(the)-315.6(utilization)-314.7(of)-318.9(cryo-)]TJ
T*
[(preserved)-358.7(sperm)-359(compared)-359.1(to)-353.7(fresh)-352(sperm,)-356.7(which)-359(has)-355.6(been)]TJ
0 -1.1174 TD
[(shown)-271.1(to)-273(result)-272.8(in)-267.3(lower)-272.6(cycle)-274.1(fecundity)-271.7(rates.)]TJ
7.3823 0 0 6.5614 496.403 170.759 Tm
(14)Tj
9.843 0 0 9.843 506.4943 166.3369 Tm
[(In)-267.1(addition,)]TJ
-19.6521 -1.1116 TD
[(these)-307.3(low)-309.6(success)-304.4(rates)-307.2(may)-305.2(suggest)-308.1(the)-304.1(limitations)-308.8(of)-307.4(ART)]TJ
T*
[(treatment)-470(for)-464(both)-459.5(lesbian)-465.1(and)-465.2(heterosexual)-467.2(patients.)-469.8(The)]TJ
0 -1.1174 TD
[(study)-230.1(may)-224.6(also)-230.1(be)-228(limited)-229.5(by)-226.8(a)-226.9(lack)-225.7(of)-226.8(information)-227.9(about)-231.4(cer-)]TJ
0 -1.1116 TD
[(tain)-351.4(diagnoses)-351.8(among)-347.7(lesbian)-344.2(patients,)-354.6(which)-347.5(could)-346.6(predis-)]TJ
T*
[(pose)-506.5(them)-496.5(to)-503.4(lower)-503(success)-500.2(rates)-503.1(\(e.g.,)-504.3(endometriosis)-501.7(or)]TJ
T*
[(PCOS\).)-465.5(In)-462.9(fact,)-465.3(some)-461.6(previous)-464.9(literature)-470(has)-459.3(suggested)-467(a)]TJ
0 -1.1174 TD
[(higher)-226.7(prevalence)-230(of)-226.8(PCOS)-224.9(among)-226.8(lesbian)-229(women)-227.6(compared)]TJ
0 -1.1116 TD
[(to)-497.7(heterosexual)-496(women,)]TJ
7.3823 0 0 6.5614 411.8739 83.0551 Tm
(15)Tj
9.843 0 0 9.843 424.1196 78.6897 Tm
[(which)-497.2(could)-490.6(explain)-494.1(reproduc-)]TJ
-11.2833 -1.1116 TD
[(tive)-420.5(outcomes)-421.3(for)-417.9(this)-419.2(sexual)-423.6(minority)-419.3(group.)-417.9(In)-416.9(addition,)]TJ
0 -1.1174 TD
[(the)-309.9(retrospective)-307.1(design)-307.2(may)-305.2(introduce)-306.2(selection)-313.1(bias)-305(in)-301.8(our)]TJ
ET
62.022 698.967 239.131 .22675 re
f
62.022 522.028 239.131 .22681 re
f
62.022 650.381 239.131 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 78.0094 725.5557 Tm
(Table)Tj
/F5 1 Tf
2.9656 0 TD
(5.)Tj
/F9 1 Tf
1.2496 0 TD
[(Pregnancy)-298.5(Outcomes)-304.2(Among)-301.3(Lesbian)]TJ
-5.1424 -1.0135 TD
[(and)-297.5(Heterosexual)-301.1(Women)-302.8(Undergoing)-306.2(Ovulation)]TJ
7.4631 -1.0135 TD
[(Induction)-305.9(Cycles)]TJ
/F6 1 Tf
1.0308 -1.9406 TD
(Lesbian)Tj
.167 -1.0135 TD
(women)Tj
-.357 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7141 0 TD
(441\))Tj
4.8602 2.027 TD
(Heterosexual)Tj
1.2554 -1.0135 TD
(women)Tj
-.6104 -1.0135 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.668 0 TD
(=)Tj
/F6 1 Tf
.7141 0 TD
(1238\))Tj
/F5 1 Tf
5.223 -1.0077 TD
(p)Tj
/F6 1 Tf
-13.5326 0 TD
.3014 Tc
(%\()Tj
/F5 1 Tf
1.4627 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
5.1549 Tc
[(\)%)4818.9(\()]TJ
/F5 1 Tf
6.9909 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
(\))Tj
/F5 1 Tf
-19.0838 -1.9003 TD
(Clinical)Tj
.9905 -1.0135 TD
[(pregnancy)-306.1(rate)]TJ
6.605 1.0135 TD
[(11.6%)-330.8(\(51/441\))-607(10.4%)-336.6(\(129/1238\))-609(0.51)]TJ
-7.5955 -2.0213 TD
(Ongoing)Tj
.9905 -1.0135 TD
(pregnancy/live)Tj
T*
[(birth)-304.7(rate)]TJ
7.106 2.027 TD
[(8.4%)-329.8(\(37/441\))-1108(7.8%)-335.6(\(97/1238\))-1109(0.71)]TJ
-8.0965 -3.0347 TD
[(Early)-301.2(pregnancy)]TJ
.9905 -1.0135 TD
[(loss)-303.2(rate)]TJ
7.106 1.0135 TD
[(2.7%)-329.8(\(12/441\))-1108(3.4%)-335.6(\(42/1238\))-1109(0.49)]TJ
-8.0965 -2.027 TD
(Clinical)Tj
.9905 -1.0135 TD
(pregnancy)Tj
0 -1.0077 TD
[(loss)-303.2(rate)]TJ
6.605 2.0213 TD
[(27.5%)-330.8(\(14/51\))-1107(24.8%)-336.6(\(32/129\))-1609(0.69)]TJ
-7.5955 -3.0348 TD
(Multiple)Tj
.9905 -1.0135 TD
[(gestation)-305.3(rate)]TJ
6.605 1.0135 TD
[(11.8%)-330.8(\(6/51\))-1607(12.4%)-336.6(\(16/129\))-1609(0.91)]TJ
ET
313.058 698.967 239.131 .22675 re
f
313.058 522.028 239.131 .22681 re
f
313.058 640.403 239.131 .22681 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 329.0456 725.5557 Tm
(Table)Tj
/F5 1 Tf
2.9657 0 TD
(6.)Tj
/F9 1 Tf
1.2496 0 TD
[(Pregnancy)-304.2(Outcomes)-298.5(Among)-307(Lesbian)]TJ
-3.9216 -1.0135 TD
[(Women)-302.8(Undergoing)-300.5(Natural)-302.2(and)-297.5(Ovulation)]TJ
6.248 -1.0135 TD
[(Induction)-300.2(Cycles)]TJ
/F6 1 Tf
2.0558 -2.9541 TD
(Natural)Tj
.3282 -1.0135 TD
(cycles)Tj
-.6565 -1.0077 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(N)Tj
/F7 1 Tf
.8868 0 TD
(=)Tj
/F6 1 Tf
.7141 0 TD
(451\))Tj
4.9178 3.0347 TD
(Ovulation)Tj
.1094 -1.0135 TD
(induction)Tj
.668 -1.0135 TD
(cycles)Tj
-.5471 -1.0077 TD
(\()Tj
/F5 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.6622 0 TD
(=)Tj
/F6 1 Tf
.7198 0 TD
(441\))Tj
/F5 1 Tf
4.4744 -1.0135 TD
(p)Tj
/F6 1 Tf
-12.5364 0 TD
.3014 Tc
(%\()Tj
/F5 1 Tf
1.4627 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
4.6539 Tc
[(\)%)4317.9(\()]TJ
/F5 1 Tf
6.4899 0 TD
0 Tc
(n)Tj
/F6 1 Tf
.501 0 TD
(\))Tj
/F5 1 Tf
-19.5848 -1.9003 TD
[(Clinical)-305.6(pregnancy)]TJ
.9962 -1.0077 TD
(rate)Tj
8.1023 1.0077 TD
[(9.5%)-329.8(\(43/451\))-607(11.6%)-336.6(\(51/441\))-607(0.32)]TJ
-9.0985 -2.0212 TD
(Ongoing)Tj
.9962 -1.0135 TD
(pregnancy/live)Tj
0 -1.0077 TD
[(birth)-299(rate)]TJ
8.1023 2.0213 TD
[(7.3%)-329.8(\(33/451\))-1108(8.4%)-335.6(\(37/441\))-607(0.55)]TJ
-9.0985 -3.0348 TD
[(Early)-306.9(pregnancy)]TJ
.9962 -1.0135 TD
[(loss)-297.5(rate)]TJ
8.1023 1.0135 TD
[(3.8%)-329.8(\(17/451\))-1108(2.7%)-335.6(\(12/441\))-607(0.38)]TJ
-9.0985 -2.027 TD
[(Clinical)-305.6(pregnancy)]TJ
.9962 -1.0077 TD
[(loss)-297.5(rate)]TJ
7.6013 1.0077 TD
[(23.3%)-330.8(\(10/43\))-1107(27.5%)-336.6(\(14/51\))-1107(0.38)]TJ
-8.5975 -2.0212 TD
[(Multiple)-304.3(gestation)]TJ
.9962 -1.0135 TD
(rate)Tj
8.8509 1.0135 TD
[(0%)-331.2(\(0/43\))-1607(11.8%)-336.6(\(6/51\))-1607(0.01)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.5368 Tm
(66)Tj
47.6178 0 TD
[(NAZEM)-308(ET)-300.7(AL.)]TJ
ET
endstream
endobj
47 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.5557 Tm
0 0 0 rg
0 Tc
0 Tw
[(results)-267.9(as)-268.1(patients)-264.8(were)-266.8(not)-262.6(randomized)-269.3(to)-261.5(groups,)-269(but)-262.6(rather)]TJ
0 -1.1174 TD
[(chosen)-400.4(based)-405.1(on)-393.9(whether)-402.7(they)-403.1(self-identied)-399.2(as)-400.6(lesbian)-401.8(or)]TJ
0 -1.1116 TD
[(heterosexual.)-326.6(How)18(eve)11.7(r,)-309.8(bot)13.8(h)-312.1(t)0(h)15(e)-313.3(uni)13.8(var)12.8(iat)12.6(e)-313.3(and)-304(mu)13.9(lti)13.6(var)12.8(iat)12.6(e)]TJ
T*
[(ana)11.7(lys)14(es,)-571(whi)13(ch)-573.6(wer)12(e)-578.2(adj)18.4(ust)14(ed)-573.6(for)-573.4(pos)14.2(sib)14(le)-573.7(co)13.9(nfo)14(und)14(ers)13(,)]TJ
T*
[(sho)14.2(wed)-287.6(con)12.8(sis)14.2(ten)12.7(t)-295(nd)14.1(ing)13.8(s.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 59.7543 660.3022 Tm
(Strengths)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 643.8613 Tm
[(Strengths)-356.5(of)-359.3(the)-355.9(study)-351(include)-361.6(a)-353.6(large)-359.3(sample)-355.7(size)-358(and)-355.8(a)]TJ
-1.0137 -1.1174 TD
[(comparative)-260.1(analysis)-258.7(of)-249.8(cycle)-256.8(types)-254.3(among)-255.6(different)-254.3(popula-)]TJ
0 -1.1116 TD
[(tions.)-291.2(It)-290.3(is)-290.1(also)-293.5(one)-292.5(of)-290.2(the)-286.8(largest)-292.3(studies)-296.7(to)-290.3(characterize)-298(uti-)]TJ
T*
[(lization)-403.3(trends)-393.6(and)-396.1(ART)-398.1(outcomes)-398.2(in)-399.7(a)-393.9(lesbian)-396(population)]TJ
T*
[(seeking)-453.5(reproductiv)-8.9(e)-445.8(care.)-454.8(The)-454.9(study)-448.9(was)-454.4(also)-454.8(performed)]TJ
0 -1.1174 TD
[(in)-347.9(a)-353.6(single)-347.7(clinic)-349.1(with)-351.1(minimal)-351.5(practice)-353.5(variation)-352.4(and)-350(stan-)]TJ
0 -1.1116 TD
[(dardized)-306.1(sperm)-301.4(processing.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 59.7543 556.6676 Tm
(Summary)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 540.2266 Tm
[(As)-290.9(access)-287.3(to)-290.3(care)-290.1(continues)-288.8(to)-284.5(improve,)-290.1(and)-286.7(more)-289(lesbian)]TJ
-1.0137 -1.1116 TD
[(couples)-217.3(engage)-211.7(in)-215.4(their)-214.2(reproductive)-212.7(journey,)-214(there)-215.3(will)-213(be)-210.7(an)]TJ
T*
[(increased)-400.4(need)-392.6(to)-394(identify)-396.2(methods)-395.9(to)-388.2(maximize)-400.9(treatment)]TJ
0 -1.1174 TD
[(success)-315.9(without)-308.5(minimizing)-308.9(the)-309.9(experience)-316.4(of)-307.4(family)-308.7(build-)]TJ
0 -1.1116 TD
[(ing.)-317.9(Personalized)-323(medicine)-324.8(is)-318.9(important)-317.9(for)-314.3(all)-321.5(patients,)-320(but)]TJ
T*
[(may)-357(be)-354.7(particularly)-357(necessary)-354(in)-353.7(the)-355.9(lesbian)-355.7(community)-353.6(as)]TJ
0 -1.1174 TD
.0122 Tc
[(these)-249.2(w)4.5(omen)-242.3(do)-248.1(n)5.3(o)-.4(t)-248.2(a)4.2(lways)-247.9(h)5.3(av)5.3(e)-249.2(a)-249.2(m)4.1(ed)5.3(ical)-248.2(d)5.3(i)-.5(agno)5.3(si)5.2(s)-247.9(o)-.4(f)-248.1(i)5.2(n-)]TJ
0 -1.1116 TD
[(fer)5.4(t)-.5(i)5.2(lit)5.2(y.)-204.3(Alth)5.3(ou)5.3(gh)-202(pregn)5.3(an)5.3(cy)-202(out)5.2(co)5.3(mes)-207.6(w)4.5(ere)-203.2(s)-.2(i)5.2(m)-1.6(i)5.2(l)-.5(ar)-207.7(amon)5.3(g)]TJ
T*
.0118 Tc
[(les)5.1(b)-.8(i)4.8(a)-2(n)-438.6(a)3.8(nd)-438.6(heteros)5.1(ex)4.9(ual)-444.4(w)4.1(omen)-438.6(u)4.9(n)-.8(d)4.9(e)-2(rg)4.9(oi)4.8(ng)-438.6(OI)-444.3(and)-438.5(I)5(UI)]TJ
0 -1.1174 TD
.012 Tc
[(wit)5(h)-426.8(cryo)5.1(pr)5.2(eserv)5.1(e)-1.8(d)-426.8(s)5.3(perm,)-429.2(t)5(he)-428(s)5.3(t)-.7(ud)5.1(y)-426.8(f)5.2(oun)5.1(d)-426.8(a)-428(h)5.1(i)-.7(g)5.1(h)-.6(er)-421(rate)]TJ
0 -1.1116 TD
.0074 Tc
[(o)-5.2(f)-425.6(m)-6.4(u).5(l)-5.3(t).4(i)-5.3(p).5(l)-5.3(e)-426.8(g)-5.2(e)-.6(s)-5(t)-5.3(at)-5.3(io)-5.2(ns)-431.2(am)-6.4(on)-5.2(g)-425.7(l).4(e)-6.4(s)-5(bi)-5.3(an)-431.4(wo)-5.2(me)-6.4(n)-425.7(u).5(n)-5.2(d).5(e)-6.4(r)-5.2(go)-5.2(in)-5.2(g)]TJ
T*
.0117 Tc
[(OI)-409.8(compared)-404.1(to)-409.9(t)4.7(h)-.9(o)4.8(s)-.7(e)-411(u)4.8(nderg)4.8(oin)4.8(g)-409.9(n)4.8(a)-2.1(tu)4.8(ral)-410(c)-2.1(y)4.8(c)-2.1(l)4.7(e)-411(IUI)-409.8(w)-1.8(i)4.7(t)-1(h)]TJ
0 -1.1174 TD
.0127 Tc
[(no)-247.6(d)5.8(i)0(ff)5.9(er)5.9(en)5.8(ce)-248.7(i)5.7(n)-247.6(pr)5.9(eg)5.8(nan)5.8(c)-1.1(y)-241.8(r).1(at)5.7(es)-247.4(b)5.8(e)-1.1(t)5.7(w)-.8(een)-247.6(t)5.7(hese)-248.7(two)-247.6(g)5.8(rou)5.8(ps)6(.)]TJ
0 -1.1116 TD
.0119 Tc
[(Giv)5(e)-1.9(n)-213.8(t)-.8(h)5(e)-215(pri)4.9(or)5.1(iti)4.9(zatio)5(n)-213.8(o)-.7(f)-213.8(a)-1.9(chievi)4.9(ng)-213.8(on)5(e)-220.7(h)5(ealth)5(y)-219.6(p)5(regn)5(ancy)]TJ
T*
[(at)-358(a)-359.1(t)4.8(ime)-359.1(i)-.9(n)-357.9(t)-.9(h)4.9(e)-359.1(eld)-357.9(o)4.9(f)-357.9(rep)4.9(r)-.8(o)4.9(ducti)4.8(ve)-359.1(med)4.9(i)-.9(cine,)-360.2(t)4.8(hi)4.8(s)-363.5(s)5.1(tu)4.9(dy)]TJ
T*
0 Tc
[(pro)14(vid)13.9(es)-296.9(new)-287.6(ins)14(igh)13.9(t)-295(reg)12.8(ard)12.8(ing)-285.7(the)-292.6(opt)13.8(im)13.7(al)-297.2(str)14.1(ate)11.5(gy)-290.2(to)-290.3(rea)11.7(ch)]TJ
0 -1.1174 TD
[(thi)13.7(s)-294.6(goa)12.8(l.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 342.992 Tm
(Conclusion)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 326.5511 Tm
[(The)-512.5(reproductive)-512.2(experience)-512.3(of)-509(lesbian)-511.2(women)-509.9(differs)]TJ
-1.0137 -1.1174 TD
[(from)-627.6(that)-622.1(of)-624.2(heterosexual)-628.4(women)-625.1(with)-627.6(infertility.)-622.2(This)]TJ
0 -1.1116 TD
[(large)-566.6(study)-564.1(is)-566.6(the)-563.3(rst)-562.8(to)-566.8(evaluate)-566.7(pregnancy)-566.3(outcomes)]TJ
T*
[(among)-606.9(lesbian)-609.1(and)-609.2(heterosexual)-611.2(women)-607.8(undergoing)-605.5(OI)]TJ
0 -1.1174 TD
[(with)-333.8(CC)-338.3(or)-330.5(letrozole)-336.3(and)-338.5(IUI)-332.4(with)-333.8(cryopreserved)-341.2(sperm,)-333.7(as)]TJ
0 -1.1116 TD
[(well)-519.3(as)-521.5(among)-520.5(lesbian)-517(patients)-523.9(undergoing)-519.1(different)-519.3(IUI)]TJ
T*
[(cycle)-285.6(types.)-286.5(Although)-286.4(pregnancy)-284.1(outcomes)-283(were)-289.8(similar)-281(be-)]TJ
T*
[(tween)-348.7(the)-344.4(groups,)-343.9(the)-338.7(multiple)-345.8(gestation)-346.5(rate)-346.6(was)-345(higher)-341.9(in)]TJ
0 -1.1174 TD
[(lesbian)-724.3(women)-717.2(undergoing)-715(OI)-723(compared)-716.2(with)-719.7(lesbian)]TJ
0 -1.1116 TD
[(women)-319.8(undergoing)-311.8(natural)-321.3(cycles.)-313(Given)-318.7(the)-315.6(importance)-315.5(of)]TJ
T*
[(singleton)-443.2(deliveries)-440.9(in)-440.1(the)-442.3(eld)-437.5(of)-439.9(reproductive)-443.1(medicine,)]TJ
0 -1.1174 TD
[(natural)-321.3(cycle)-325.9(IUI)-320.9(may)-316.7(be)-320.1(a)-319(safer)-324.4(way)-322.1(for)-320(lesbian)-321.1(women)-319.8(to)]TJ
0 -1.1116 TD
[(achieve)-306.2(a)-301.8(successful)-307.8(pregnancy.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 173.0834 Tm
(Acknowledgments)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 156.6425 Tm
[(The)-207.3(authors)-204.6(acknowledge)-213.6(all)-206.3(the)-206.2(physicians)-209(and)-206.1(laboratory)]TJ
-1.0137 -1.1116 TD
[(staff)-300.3(at)-297.2(Reproductive)-300.2(Medicine)-295.7(Associates)-303(of)-295.9(New)-299.9(York)-293.2(for)]TJ
T*
[(their)-375.5(contribution)-372(to)-370.9(patient)-373.3(care,)-374.2(without)-371.8(which)-376.3(this)-367.3(study)]TJ
T*
[(would)-306(not)-297.2(be)-302.9(possible.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 101.8771 Tm
[(Author)-307.1(Disclosure)-298.8(Statement)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 85.4362 Tm
[(No)-302.6(competing)-301.7(nancial)-306.1(interests)-300.2(exist.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 726.1227 Tm
(References)Tj
/F5 1 Tf
9.2951 0 0 9.2951 315.496 710.0786 Tm
[(1.)-500.4(Kop)-276.5(PA,)-273.2(van)-279.1(Wely)-276.9(M,)-273.9(Mol)-279.7(BW,)-277.9(et)-272.3(al.:)-278(Intrauterine)-281.9(insemi-)]TJ
1.2503 -1.1284 TD
[(nation)-589.5(or)-594.2(intracervical)-592.5(insemination)-592.1(with)-592.6(cryopreserved)]TJ
0 -1.1223 TD
[(donor)-472.7(sperm)-481.7(in)-475.4(the)-473.7(natural)-480.2(cycle:)-482(A)-477.5(cohort)-476.5(study.)-475.1(Hum)]TJ
0 -1.1284 TD
[(Reprod)-298.8(2015;30:603607.)]TJ
-1.2503 -1.1223 TD
[(2.)-500.4(Marina)-278.7(S,)-271.5(Marina)-284.8(D,)-276.3(Marina)-278.7(F,)-271.5(et)-278.4(al.:)-278(Sharing)-278.2(motherhood:)]TJ
1.2503 -1.1284 TD
[(Biological)-317.3(lesbian)-312.4(co-mothers,)-317.7(a)-315.4(new)-311.2(IVF)-318.3(indication.)-312.6(Hum)]TJ
0 -1.1223 TD
[(Reprod)-298.8(2010;25:938941.)]TJ
-1.2503 -1.1284 TD
[(3.)-500.4(Nordqvist)-271.5(S,)-265.4(Sydsjo)]TJ
8.8927 .0244 TD
()Tj
.6831 -.0244 TD
[(G,)-270.2(Lampic)-272.4(C,)-267.3(et)-272.3(al.:)-271.9(Sexual)-267.8(orientation)]TJ
-8.3255 -1.1223 TD
[(of)-210(women)-213.5(does)-211.3(not)-207.2(affect)-212.7(outcome)-215.8(of)-210(fertility)-208.5(treatment)-215.4(with)]TJ
0 -1.1284 TD
[(donated)-301.6(sperm.)-298.8(Hum)-300.4(Reprod)-304.9(2014;29:704711.)]TJ
-1.2503 -1.1223 TD
[(4.)-500.4(Ferrara)-578.5(I,)-582(Balet)-580(R,)-578.3(Grudzinskas)-578.8(JG:)-580(Intrauterine)-586.8(donor)]TJ
1.2503 -1.1284 TD
[(insemination)-281(in)-280.3(single)-283.6(women)-280.5(and)-285.2(lesbian)-281.9(couples:)-282(A)-282.3(com-)]TJ
0 -1.1223 TD
[(parative)-417.5(study)-414(of)-417.4(pregnancy)-412.7(rates.)-418.7(Hum)-416.3(Reprod)-414.7(2000;15:)]TJ
0 -1.1284 TD
(621625.)Tj
-1.2503 -1.1223 TD
[(5.)-500.4(Ferrara)-346.7(I,)-350.2(Balet)-348.2(R,)-346.6(Grudzinskas)-347(JG:)-348.2(Intrauterine)-349(insemina-)]TJ
1.2503 -1.1284 TD
[(tion)-341(with)-342.6(frozen)-337.2(donor)-344.6(sperm.)-341.5(Pregnancy)-342.4(outcome)-343.9(in)-341.3(rela-)]TJ
0 -1.1223 TD
[(tion)-408.1(to)-408.4(age)-411.4(and)-407.2(ovarian)-407.6(stimulation)-416.4(regime.)-407.1(Hum)-410.2(Reprod)]TJ
0 -1.1284 TD
(2002;17:23202324.)Tj
-1.2503 -1.1223 TD
[(6.)-500.4(Hodson)-233.3(K,)-239.7(Meads)-239.3(C,)-230.7(Bewley)-240.7(S:)-234.4(Lesbian)-241.6(and)-236.4(bisexual)-239.3(wom-)]TJ
1.2503 -1.1284 TD
[(ens)-280.7(likelihood)-283.9(of)-277.1(becoming)-283(pregnant:)-285.4(A)-282.3(systematic)-284.6(review)]TJ
0 -1.1223 TD
[(and)-297.4(meta-analysis.)-310(BJOG)-300.4(2017;124:393402.)]TJ
-1.2503 -1.1284 TD
[(7.)-500.4(Rotterdam)-789.8(ESHRE/ASRM-Sponsored)-797.2(PCOS)-793.4(consensus)]TJ
1.2503 -1.1223 TD
[(workshop)-229.9(group:)-234.4(Revised)-232.3(2003)-232.4(consensus)-232.7(on)-232.1(diagnostic)-232.9(cri-)]TJ
0 -1.1284 TD
[(teria)-315.3(and)-309.6(long-term)-319.6(health)-313.1(risks)-317.9(related)-313.7(to)-310.8(polycystic)-318.3(ovary)]TJ
0 -1.1223 TD
[(syndrome)-299.1(\(PCOS\).)-304.4(Hum)-300.4(Reprod)-298.8(2004;19:4147.)]TJ
-1.2503 -1.1284 TD
[(8.)-500.4(Ethics)-438(Committee)-438.9(of)-435.6(American)-443.6(Society)-438.1(for)-438.1(Reproductive)]TJ
1.2503 -1.1284 TD
[(Medicine:)-414(Access)-421.9(to)-414.5(fertility)-415.9(treatment)-416.6(by)-415(gays,)-418.7(lesbians,)]TJ
0 -1.1223 TD
[(and)-346.2(unmarried)-348.8(persons:)-353(A)-349.4(committee)-346.8(opinion.)-347.6(Fertil)-350.1(Steril)]TJ
0 -1.1284 TD
(2013;100:15241527.)Tj
-1.2503 -1.1223 TD
[(9.)-500.4(Carpinello)-228.7(OJ,)-226.7(Jacob)-227.8(MC,)-224(Nulsen)-230.9(J,)-225(et)-223.5(al.:)-229.2(Utilization)-227.7(of)-228.3(fer-)]TJ
1.2503 -1.1284 TD
[(tility)-223.7(treatment)-233.7(and)-224.2(reproductive)-231.3(choices)-225.7(by)-226(lesbian)-227(couples.)]TJ
0 -1.1223 TD
[(Fertil)-301.3(Steril)-301.3(2016;106:17091713.e4.)]TJ
-1.7505 -1.1284 TD
[(10.)-500.5(Society)-249(for)-242.9(Assisted)-247.1(Reproductive)-252.1(Technology:)]TJ
/F6 1 Tf
21.018 0 TD
[(2014)-244.5(Clinic)]TJ
-19.2675 -1.1223 TD
[(Summary)-452.7(Report)]TJ
/F5 1 Tf
6.9531 0 TD
[(.)-451.4(Birmingham,)-456.1(AL:)-454.7(Society)-456.4(for)-456.4(Assisted)]TJ
-6.9531 -1.1284 TD
[(Reproductive)-300.9(Technology,)-304(2014.)]TJ
-1.7505 -1.1223 TD
[(11.)-500.5(Stoffel)-371.5(C,)-371(Carpenter)-376.5(E,)-368.1(Everett)-378.4(B,)-370.9(et)-369.9(al.:)-375.6(Family)-372.3(planning)]TJ
1.7505 -1.1284 TD
[(for)-383.2(sexual)-386(minority)-379.5(women.)-390.4(Semin)-378.9(Reprod)-390.3(Med)-382.1(2017;35:)]TJ
0 -1.1223 TD
(460468.)Tj
-1.7505 -1.1284 TD
[(12.)-500.5(Fiske)-225.9(E,)-221.7(Weston)-227.5(G:)-220.9(Utilisation)-228.7(of)-222.2(ART)-228.2(in)-225.4(single)-222.6(women)-225.7(and)]TJ
1.7505 -1.1223 TD
[(lesbian)-300.2(couples)-300.7(since)-306.5(the)-302.9(2010)-299.4(change)-300.2(in)-298.6(Victorian)-304.7(legisla-)]TJ
0 -1.1284 TD
[(tion.)-298.4(Aust)-299.6(N)-300.6(Z)-300.9(J)-304.2(Obstet)-297.4(Gynaecol)-307.6(2014;54:497499.)]TJ
-1.7505 -1.1223 TD
[(13.)-500.5(De)-335.4(Brucker)-342.1(M,)-334.9(Camus)-343.9(M,)-334.9(Haentjens)-342.8(P,)-338.6(et)-339.4(al.:)-339(Cumulative)]TJ
1.7505 -1.1284 TD
[(delivery)-205.9(rates)-205.2(after)-208.4(ICSI)-202(with)-208.4(donor)-204.3(spermatozoa)-207.9(in)-201(different)]TJ
0 -1.1223 TD
[(age)-301.6(groups.)-301.2(Reprod)-298.8(Biomed)-301.6(Online)-304.4(2014;28:599605.)]TJ
-1.7505 -1.1284 TD
[(14.)-500.5(Subak)-300.6(LL,)-309.1(Adamson)-304.3(GD,)-308.5(Boltz)-301.3(NL:)-308.3(Therapeutic)-308.1(donor)-301.9(in-)]TJ
1.7505 -1.1223 TD
[(semination:)-317.5(A)-312.8(prospective)-313.4(randomized)-320.4(trial)-310.5(of)-313.7(fresh)-319.7(versus)]TJ
0 -1.1284 TD
[(frozen)-532.4(sperm.)-536.6(Am)-532.1(J)-529.9(Obstet)-535.3(Gynecol)-535(1992;166\(6)-533.8(Pt)-533.2(1\):)]TJ
0 -1.1223 TD
[(15971604;)-299.8(discussion)-300.7(16041606.)]TJ
-1.7505 -1.1284 TD
[(15.)-500.5(Agrawal)-221.7(R,)-224.6(Sharma)-221.4(S,)-216.6(Bekir)-224.9(J,)-218.9(et)-223.5(al.:)-223.1(Prevalence)-222.3(of)-222.2(polycys-)]TJ
1.7505 -1.1223 TD
[(tic)-210.9(ovaries)-217.7(and)-212(polycystic)-214.6(ovary)-208.5(syndrome)-213.8(in)-213.2(lesbian)-214.8(women)]TJ
0 -1.1284 TD
[(compared)-345(with)-342.6(heterosexual)-342.1(women.)-341.6(Fertil)-344(Steril)-344(2004;82:)]TJ
0 -1.1223 TD
(13521357.)Tj
9.843 0 0 9.843 439.4266 150.1795 Tm
[(Address)-303.1(correspondence)-309(to:)]TJ
/F6 1 Tf
-.4665 -1.1116 TD
[(Taraneh)-302.3(Gharib)-301.2(Nazem,)-305.6(MD)]TJ
-7.5798 -1.1116 TD
[(Reproductive)-307.1(Medicine)-301.6(Associates)-308(of)-296.1(New)-306(York)]TJ
5.8 -1.1174 TD
[(635)-302.8(Madison)-302.5(Avenue,)-302.7(10th)-298.3(Floor)]TJ
4.9361 -1.1116 TD
[(New)-306(York,)-296.6(NY)-302.6(10022)]TJ
-3.1909 -2.1253 TD
(E-mail:)Tj
/F5 1 Tf
3.3637 0 TD
(tnazem@rmany.com)Tj
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.5368 Tm
[(UNDERSTANDING)-308.8(THE)-303.5(LESBIAN)-304.3(REPRODUCTIVE)-302.5(EXPERIENCE)-22856.8(67)]TJ
ET
endstream
endobj
50 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
53 0 obj
<>stream
hބTPckG c%pHj QI0X܉ȑ;$ !"D?XLcҘƤTLH/hLLLӉ:]Sәv:߷;ꈟt%-KHMOJMNoX,ǝ\0}%uDgP>[㈉ypb^ۜv5.orEyNWe-j|a:nTjWK%